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Clinical Problem: Prostate cancer is the most common cancer among men in the United States 
and is the leading cause of death (CDC, 2021). Etiology of prostate cancer remains unclear but in 
recent research it has been shown that there is an association between occupation and prostate 
cancer risk (Sritharan, et al., 2019). Specifically protective service occupations including 
firefighters, policeman and detectives, guards, and watchmen (Sritharan et al., 2019). 
Significance: With new evidence of risk factors, it is important that these individuals understand 
that they are at an increased risk of being diagnosed with prostate cancer. In 2018, New York 
State reported 15,714 cases of prostate cancer. With such a high incidence it is important that 
these individuals are participating in secondary prevention measures in the hopes that prostate 
cancer is caught early. 
PICOT Question: This EBP proposal is framed around the following PICOT question:  
Among persons who are in protective service occupations, what is the impact of a Nurse 
Practitioner led shared decision coaching program that utilizes a decision aid on improved 
knowledge of prostate cancer, confidence in shared decision making for prostate cancer 
screening and patient satisfaction over 12 weeks? 
Clinical Change: The change that will be implemented in this proposal is a nurse practitioner 
led shared decision coaching that will occur in a primary care setting with participants in 
protective service occupations. Education will be provided during the decision coaching and an 
opportunity to ask questions about prostate cancer and an individual’s specific risk factors will 
be allotted. Following the decision coaching the patient will be given the choice to have a PSA 
test ordered for them and if they decide to follow through with PSA testing, the nursing staff 
with take their blood draw then. 
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Desired Outcome: The desired outcome of this evidence-based proposal will include improved 
knowledge of prostate cancer specifically anatomy and function, risk factors, screening, and 
symptoms of prostate cancer. Other outcomes include increase in PSA testing with improved 
confidence in decision making regarding the testing and improved satisfaction with the 
interaction between the patient and nurse practitioner.  
Summary: Through a review and synthesis of the literature, it was determined that the use of 
decision coaching and the use of decision aids are effective interventions for improving 

















Keywords: prostate cancer, PSA testing, protective service occupations, shared decision making, 
informed decision making 
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An Evidence-Based Proposal Supporting Prostate Specific Antigen in Protective Service 
Occupations 
Prostate cancer is the most common cancer among men in the United States and is one of 
the leading causes of cancer death in men of all races (CDC, 2021). The latest incidence data 
from the Centers for Disease Control and Prevention is from 2018. In 2018, it was noted that in 
the United States there was 211,893 new cases of prostate cancer reported, and 31,488 men died 
from prostate cancer (CDC, 2021). For every 100,00 men, 108 new prostate cancer cases were 
reported, and 31 men passed away (CDC, 2021). In New York state specifically, the age adjusted 
rate of new cases were 132.4 per 100,000 (CDC, 2021).  New York State had a total of 15,714 
cases reported that year.  
 The etiology, also known as the cause of prostate cancer, remains unclear but the most 
well-established risk factors include age, family history of prostate cancer, and ethnicity 
(Sritharan et al., 2018). Other risk factors potentially contributing to higher rates of prostate 
cancer include diet, obesity, smoking, sexual behavior, sexually transmitted disease, genetic 
mutations, hormone levels, and occupation (Sritharan et al., 2018).  Men older than the age of 50 
and of African American ethnicity, as well as men who have a family history of the cancer, are at 
an increased risk of prostate cancer and are more likely to seek out secondary prevention 
measures (Sritharan et al., 2019). Recent studies completed in Canada examined work-related 
risk factors for prostate cancer and have shown an association between employment and prostate 
cancer risk (Sritharan, et al., 2019). The occupations at higher risk for prostate cancer include 
management and administration, farming, construction, transportation, and protective service 
occupations including firefighters, policeman and detectives, guards, and watchmen (Sritharan et 
al., 2019).  The results of Sritharan et al. (2019), suggest that night shift work is associated with 
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prostate cancer and that those are frequent hours that protective service occupations work. 
Significant elevated risks were observed across protective services occupations for firefighters 
and police officers but there was no observed significant increased risk for armed forces and 
other protective services (Sritharan et al, 2018). The logic surrounding the increased risk of 
prostate cancer in protective services occupations involves increased exposure to diesel exhaust, 
dust and particulate matter, chemical agents, and radiation (Sritharan et al., 2018). Many 
overnight protective service occupations may also have a disruption in their circadian rhythm 
due to the hours of work (Sritharan et al., 2019). Protective service occupations can also be under 
constant psychological stress which may impact biological processes leading to the development 
of cancer (Sritharan et al., 2018).  Even though the etiology remains unclear on prostate cancer, 
there is an obvious and documented correlation between prostate cancer and protective service 
occupations.  
Because it is known that persons in service occupations have a higher risk of prostate 
cancer occurrence, it is important to implement prevention strategies in this population. Primary 
prevention and early intervention for prostate cancer may include measures such as diet and 
lifestyle modification and education programs promoting healthy living and early screening. 
Secondary prevention measures are screenings to identify disease in the earliest stages, 
before the onset of signs and symptoms of a disease, examples include mammography and 
regular blood pressure testing (Prevention, n.d.). Secondary prevention measures are also 
important to managing prostate cancer cases. Secondary prevention includes screening for 
prostate cancer using the Prostate Specific Antigen (PSA) test and digital rectal exams (DRE). 
The PSA is a blood test that measures the level of PSA in the blood (CDC, 2021). Prostate 
Specific Antigen is a substance made by the prostate that can be elevated in individuals who 
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have prostate cancer as well as in persons with other conditions that affect the prostate such as an 
enlarged prostate, prostate infection, certain medical procedures, and certain medications (CDC, 
2021).  A normal PSA level is between 1-1.5 ng/ml. An above normal PSA level in the blood 
tends to a greater likelihood that a prostate problem is present (CDC, 2021). There are many 
factors that can affect the PSA level including an increased age and African American race. 
Another secondary prevention measure is a Digital Rectal Examination (DRE). The DRE is 
when a health care provider inserts a gloved lubricated finger into a man’s rectum to feel the 
prostate for anything abnormal such as a tumor (CDC, 2021). A DRE is not currently 
recommended by the U.S. Preventative Services Task Force (USPSTF) as a screening test 
because of the lack of evidence on the benefits (CDC, 2021).  
Many facilities and providers respect the USPSTF recommendations when it comes to 
cancer screening recommendations. The USPSTF is an independent, volunteer panel of national 
experts in prevention and evidence-based medicine that works to improve the health of people 
nationwide by making evidence-based recommendations about clinical preventive services such 
as screenings, counseling services, and preventive medications (U.S. Preventative Service Task 
Force, n.d.).  The USPSTF uses a grading scale (Grade A, B, C, D, and I) to determine the 
suggestions of practice. The USPSTF recommendation for prostate cancer screening for men 
between the ages of 55 through 69 is a Grade C (U.S. Preventative Service Task Force, 2018). 
The Grade C prostate cancer recommendation includes that the decision to undergo periodic PSA 
based screening for prostate cancer should be an individual one (U.S. Preventative Service Task 
Force, 2018). Providers and patients should consider the balance of benefits and harms based on 
family history, race/ethnicity, comorbid medical conditions, patient values about the benefits and 
harms of screening and treatment specific outcomes and other health needs (U.S. Preventative 
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Service Task Force, 2018).  Clinical decisions about PSA testing involve more considerations 
than evidence alone and should be individualized with each patient (Jama, 2018). Before one 
decides to proceed or not with the PSA test, one should have the opportunity to discuss the 
potential benefits and harms of screening with their provider and should incorporate their values 
and preferences in the decision (U.S. Preventative Service Task Force, 2018).  
There is an uncertainty that is associated with PSA testing and the USPSTF recommends 
a discussion occur between the patient and provider about the risks and benefits of PSA testing. 
This can be called shared decision making (SDM) between patient and provider. Since the 
introduction of SDM, decision-making studies have shown that the patient-provider 
conversations are not occurring (Hopper, et al., 2017). In Hopper et al. (2017), the authors 
explored the barriers to prostate cancer screening and identified that there was a variation in 
patient-provider communication. Several participants felt that appointments with their providers 
were rushed or too short leading to the patient coming prepared the next time with notes on 
questions to ask (Hopper et al., 2017). Others felt that their provider never discussed prostate 
cancer screening with them or when discussed, they did not give them enough time to make an 
informed decision about the screening (Hopper et al., 2017).  Participants also expressed the 
need for more information about prostate cancer symptoms, risks for developing prostate cancer, 
prostate cancer screening, and information about follow up for repeat PSA testing (Hopper et al., 
2017). This research has shown that some individuals are not engaging in SDM with their 
provider. It would be beneficial to both the patient and the provider if SDM occurred with the 
use of a decision aid to help provide better education on prostate cancer and give individuals the 
knowledge and time to make an informed decision.  
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Definition of Terms 
During this evidence-based proposal the reader may come across some terms that they 
are not familiar with. These are terms will be used frequently in this proposal.  
 Protective Service Occupation: Firemen both volunteer and paid, investigators, 
police officers and detectives.  
 Motivational Interviewing: An interviewing technique that allows for a genuine 
conversation to occur between the patient and nurse practitioner.  
 Shared Decision Making: A patient deciding with the nurse practitioner on their 
specific risks and benefits of going through with PSA testing.  
 Decision Aid: A tool that provides education about prostate cancer which aids in 
increasing knowledge.  
 Informed Decision Making: A patient has all the information and education on 
risks and benefits of PSA testing that will lead to them making the nest decision 
for themselves.  
Identification of Problem 
 The literature supports prostate cancer is one of the most common cancers without clear 
etiology. It is known that prostate cancer is more common in African American men, in 
individuals with a family history of prostate cancer and in those over the age of 65. The literature 
also supports those occupational hazards are common to specific occupations such as protective 
service occupations. This occupation can increase the risk of being diagnosed with prostate 
cancer. The USPSTF recommends PSA screening in individuals at risk for being diagnosed with 
prostate cancer. It is important for individuals to be informed properly and to not make decisions 
on PSA testing when the risks and benefits of testing are not clearly understood. Even with the 
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USPSTF recommendations being published regarding prostate cancer screening, an increase in 
communication and SDM between providers and patients has not been experienced (U.S. 
Preventative Service Task Force, 2018). With the absence of conversations and SDM, there is a 
risk that those who are at increased risk of prostate cancer will not be screened and will not 
receive proper recommended PSA testing.  
Significance of the Clinical Problem 
Protective service occupations, whether it be fireman, policemen, or detectives, have an 
increased risk of being diagnosed with prostate cancer (Sritharan et al, 2018). With proper cancer 
screening in individuals who do have a greater risk of being diagnosed with prostate cancer, an 
earlier diagnosis may lead to improved outcomes. With 31,488 deaths in the United States in 
2018, there is no doubt that prostate cancer is prevalent. Engaging high risk patients in SDM and 
informed decision making will increase knowledge of the risks, and benefits to screening for 
prostate cancer. Early screening has the potential to increase survival rate with earlier detection 
and less invasive treatment options.  
EBP Proposal Purpose 
The purpose of this EBP proposal is to improve knowledge on prostate cancer, ensure 
that there is a productive engagement of shared decision making between the nurse practitioner 
and those in the protective service occupations and improve the patient’s confidence in their 
decision regarding PSA screening. The process of SDM, increased risk communication and the 
use of the decision aid is intended to increase overall patient satisfaction including satisfaction 
with communication between patient and nurse practitioner.  
PICOT Question 
This EBP proposal is framed around the following PICOT question:  
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Among persons who are in protective service occupations, what is the impact of a Nurse 
Practitioner led shared decision coaching program that utilizes a decision aid on 
improved knowledge of prostate cancer, confidence in shared decision making for 
prostate cancer screening and patient satisfaction over 12 weeks? 
Summary 
Chapter one has presented data on the prostate cancer prevalence, etiology, and primary 
and secondary prevention measures as well as screening using the PSA and DRE. Presented were 
the USPSTF recommendations for prostate cancer screening and the use of shared decision 
making. It is known that prostate cancer is seen more frequently in protective service 
occupations such as firefighters and police officers. It is of prime importance that interventions 
include the use of SDM in the protective service occupation employee that includes coordination 
with the NP who can guide the patient toward EBP education and screening. Chapter two will 
provide a review of the literature and presentation of the evidence to support a change in prostate 
screening using SDM in protective service occupations.  
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Chapter Two: Synthesis of the Evidence 
 A thorough search of the literature was conducted to gather support for this evidence-
based proposal. The three main themes that emerged from the literature are: 1) Shared Decision 
Making (SDM) between the Nurse Practitioner and the patient 2) Community Health Workers 
and Motivational Interviewing and 3) The use of a decision aid to provide better education to the 
patient. A comparison will be drawn between the role of the nurse practitioners as a community 
health worker or health coach in the decision-making process for prostate cancer screening. A 
synthesis of the literature will be presented in this chapter. 
Search Strategies 
 Various search strategies and databases were used to gather quality research and literature 
to the relevant topic that is discussed in this evidence-based proposal. The main databases used 
were MEDLINE with full text and CINAHL. Access to full-text articles were obtained via the 
Daemen College Library website. Keywords that were used to search for appropriate literature 
included “shared decision making”, “prostate cancer”, “community health coaching”, 
“motivational interviewing”, and “decision aid”. All articles were derived from scholarly and 
peer-reviewed sources and have been published with the last five years (2016 to 2021) except for 
two articles that were published in 2015 and 2012. Articles were chosen based on the relation to 
prostate cancer, secondary prevention measures, community health workers and decision aids.  
Articles did not need to include all the criteria listed above. The level of evidence in this 
literature review is primarily level I. Ten out of the fifteen articles are level I. Level I articles are  
experimental studies, randomized controlled trials (RCT), and systemic reviews of RCT with or 
without meta-analysis. Two out of the fifteen articles used level II evidence, this included quasi-
experimental study, systemic review of a combination of RCTs and quasi-experimental studies 
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only, with or without meta-analysis. Three out of the fifteen articles were level V. Level V 
evidence includes literature reviews. Refer to appendix A for a matrix review of the literature.   
Synthesis of the Evidence 
Theme One: Shared Decision-Making  
The first theme that emerged from the literature was the importance of shared decision 
making between the nurse practitioner (NP) and the patient. This theme was prevalent in two 
studies completed by Stamm et al. (2017), and Makarov et al. (2021). As explained in chapter 
one, it is important to understand that the decision on whether to screen for prostate cancer or not 
is the patient’s choice. At the same time as the choice for screening is the patient’s, the role of 
the NP to assist the patient with understanding his risk of developing prostate cancer, the 
benefits, and risks of testing so that an informed decision can be made.    
The purpose of the Stamm et al. (2017), study was to evaluate whether the use of a 
decision aid with or without shared decision making during a primary care visit influenced 
knowledge of prostate cancer screening and rates of PSA-based prostate cancer screening. The 
results were identified by stratifying outcomes by short term provider relationship (STPR) and 
long-term provider relationship (LTPR). Stamm et al. (2017), stated that shared decision making 
(SDM) in prostate cancer screening should have three components: The patient must have a 
defined choice; the patient must be apprised of his options; and lastly, the decision must ensue 
based upon the patient’s values, preferences, and provider guidance. Stamm et al. (2017), 
discussed that the patients who had a decision aid along with SDM were significantly more 
likely to report the possibility of a diagnostic procedure or surgery compared to those who 
received usual care. Participants who received a decision aid alone were significantly less likely 
to report that they always felt encouraged to discuss all health concerns. The overall results of 
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the study showed that the use of a decision aid alone is an inadequate substitute for a direct 
conversation between patients and providers through SDM.  
Makarov et al. (2021), discussed the use of community health workers (CHW) and 
decision coaching to promote SDM for prostate cancer screening. The purpose of the study is to 
evaluate the efficacy of a community health worker led decision-coaching program to facilitate 
SDM for prostate cancer screening among black men in the primary care setting. It is known that 
CHW-led interventions improve awareness, knowledge, support, and efficacy to reduce the 
impact of chronic disease and cancer in underserved populations (Makarov, et al., 2021). With 
this knowledge it seems that CHW’s are ideally suited to help primary care practices seeking to 
facilitate SDM for PSA screening. This study is currently ongoing with an anticipated 
completion in March of 2023. The anticipated result of the study is that the use of a CHW led 
decision coaching will improve or optimize decision quality regarding prostate cancer screening.  
Theme Two:  Community Health Worker and Motivational Interviewing  
 The second theme that emerged from the literature was that CHW’s and motivational 
interviewing (MI) improved behavior and knowledge or education on disease processes. The 
theme was prevalent in many of the articles that were reviewed (Alaofè, et al., 2017; Alizadeh-
Sabeg , et al., 2021; Brandford et al., 2018; Kim et al., 2016; Makarov et al., 2021; Palmas, et al., 
2015; Portillo, Vasquez & Brown 2020; Stacey, et al., 2012; Roland et al, 2017).  Kim et al. 
(2016), conducted a review of studies that looked at the impact of community-based health 
workers (CBHW). Most studies focused on preventing cancer and cardiovascular disease. The 
tasks that were carried out in these studies included providing education and counseling, helping 
patients navigate the health care system, managing care, and providing social services and 
support when needed. The interventions completed by CBHW were performed in collaboration 
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with other health care professionals such as primary care providers. In total, 30 studies tested the 
effect of CBHW-led intervention on cancer control, 21 of the studies (70%) found improvements 
in cancer screening behaviors. The CBHW builds trust and rapport and can communicate with 
the community; thus, explaining why CBHWs play an important role in patient-center care 
teams.  
Similarly, Roland et al. (2017), identified 24 articles that all reported positive outcomes 
of CHW interventions within federally qualified health centers. According to Roland et al. 
(2017), the CHW's efforts have led to an increase in cancer screening and timely completion of 
diagnostic follow-up and cancer treatment initiation.  
Makarov et al. (2021), is an ongoing study that proposed that a CHW-led decision 
coaching program facilitates SDM for prostate cancer screening discussions in black men in a 
primary care setting. The anticipated outcome of the study that there will be an increase in PSA 
screening. There will also be improvement and optimized decision quality. Another outcome that 
is anticipated is that there will be improved behaviors and norms surrounding PSA screening.  
For the last 19 years Americans have rated the honesty and ethics of nurses highest 
among a list of professions that Gallop asked the U.S. adults to assess annually (Reinhart, 2020).  
In 2020, 85% of Americans stated nurses’ honesty and ethical standards are “very high” or 
“high” (Reinhart, 2020).  The American Association of Nurse Practitioners (2019) explained that 
seeing a nurse practitioner for care has been tied to having higher rates of satisfaction, more 
health counseling added focus on prevention, improved communication, greater follow up, fewer 
emergency room visits, and more time spent with patients. All NP’s start off their career as 
registered nurses (RN) and may progress to become NPs. Many qualities such as honesty and 
ethics remain as core values in NPs from their time spent as RNs. It can be assumed that higher 
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rates of satisfaction and improved communication with NPs can be attributed to the time spent in 
the role of an RN, trust built in the NP who function as an RN, improved communication skills, 
increased follow-up and increased time spent with patients. Nurse practitioners can make great 
health coaches who can help move patients to decision making.    
Alizadeh-Sabeg et al. (2021), used a randomized control trial to study the effect of 
motivational interviewing (MI) on the change in breast cancer screening behaviors. Motivational 
interviewing is considered a client-centered approach, aimed at improving the motivation of 
clients to change their behavior over time. The results of the Alizadeh-Sabeg et al. (2021), study 
showed that MI-based counseling increased women’s motivation for displaying breast cancer 
screening behaviors. Before the MI-based counseling, participants were in the contemplation 
stage but after the intervention (MI-based counseling sessions) most participants entered the 
action stage for self-breast checking and clinical breast examination. 
Stacey et al. (2012), is an older article but serves to provide adequate information in 
decision coaching. In this systemic review, Stacy et al. (2012), explored characteristics and 
effectiveness of decision coaching evaluated within trials of patient decision aids (PtDAs) for 
health decisions. Decision coaching used with PtDAs compared to usual care showed an 
improvement in knowledge and participation in decision making without any report of 
dissatisfaction. It was also mentioned that decision coaching by someone within the health care 
team is one strategy for ensuring relevant PtDAs are subsequently discussed with the patients. 
The NP functioning in the role of a decision coach in the health care team can ensure relevant 
information regarding prostate cancer will be discussed with patients in this EBP. 
Palmas et al. (2015), reviewed the efficacy of CHW intervention to improve glycemia in 
people with diabetes as opposed to usual care. The interventions included education provided by 
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a diabetes educator, being managed by a diabetes nurse, or receiving a 6-month diabetes self-
management education program. Those were received a 6-month diabetes self-management 
education program later  Articles that were reviewed compared the use of a CHW such as a 
diabetes educator to the usual care that they would receive. The meta-analysis suggested the use 
of CHW lasting at least 12 months resulted in a modest reduction of hemoglobin Alc compared 
to usual care. It was also discussed that studies that have a more visit intensive CHW protocol 
might have had greater efficacy. Similarly, Alaofè et al. (2017), discussed diabetes prevention 
and management with the use of CHW interventions. These interventions included providing 
nutritional education and established appropriate daily exercise activities for 3 months. Ten 
studies were reviewed, and seven of the ten positive outcomes were observed. These positive 
outcomes included increased knowledge of type 2 diabetes mellitus symptoms and prevention 
measures; increased adoption or treatment-seeking and prevention measures; increased 
medication adherence; and improved fasting blood sugar, glycated hemoglobin, and body mass 
index. Both articles used community health workers and interventions that improved health 
promotion behavior and showed a reduction in Hemoglobin Alc. The use of CHWs can improve 
knowledge of prostate cancer and potentially improve confidence in shared decision making for 
prostate cancer screening and patient satisfaction. Nurse practitioners taking on the role of CHW 
would positively effect teaching because they have the knowledge of prostate cancer, diagnostic 
procedures, and secondary prevention measures. They would also be able to answer questions 
that the participants may have during the session. 
 Portillo, Vasquez, and Brown (2020), explained that MI is a client-centered technique 
intended to bring awareness to risky behaviors and increase the chances that the person will 
change their behavior. It was shown that MI adherence by CHWs improves over time and is 
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achievable. Nurse Practitioners, by their training, are adept with MI techniques. Portillo et al. 
(2020), discussed the CHWs serving as a bridge between the community and health-care 
professionals due to their ability to empathize with participants. Lastly, Branford et al. (2019),  
described the feasibility of training CHWs to deliver MI to promote cancer screening in 
underserved populations. The article concluded that one of the most powerful strategies to 
address cancer disparities in the use of CHWs to influence behavior surrounding cancer 
screening. When CHWs were trained to use MI, the CHWs felt that it was feasible and valuable 
to the work of promoting cancer screening in underserved populations (Branford et al., 2019). 
The behavior change desired in this EBP would be improved knowledge of prostate 
cancer, confidence in SDM for prostate cancer screening and patient satisfaction. As nurses and 
NPs are one of the most trusted professions, the NP has an ability to empathize with patients 
making them an ideal CHWs or decision coaches. Implementing the NP as a decision coach who 
uses SDM and MI strategies in protective service occupations who are at greater risk for 
developing prostate cancer may improve adherence to prostate cancer screening.  
Theme Three: The Use of a Decision Aid  
 Lastly, the third theme that was established from the matrix was the use of a decision aid 
to help the nurse practitioner in engaging in SDM (Allen, Filson, & Berry, 2020; Allen, et al., 
2019; Owens, et al., 2018; Owens, Wooten, & Tavakoli, 2019; Rim, et al., 2018; Stacey, et al., 
2012).  Decision aids are patient based tools developed to help patients make medical decision 
about their healthcare (O’Conner, et al., 2009). Approximately half of the articles reviewed 
discussed the effective use of a decision aid.  
 Owens et al. (2018), explained that informed decision making (IDM) is characterized by 
a patient having a clear understanding about the disease, possessing knowledge of the risks, 
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benefits, and uncertainties of screening and subsequent treatment, and actively engaging at the 
level of decision-making desired. The decision aid that Owens et al. (2018), specifically used 
was iDecide, which is an embodied conversational agent-led, computer-based prostate cancer 
screening decision aid. The use of iDecide increased knowledge of prostate cancer as well as 
vastly improving informed decision-making self-efficacy. Over half of the men that participated 
in the study reported that they intend to participate in IDM with their healthcare provider within 
the next six months.  
Rim et al. (2018), examined current primary care providers’ perspectives on the use of 
decision aids (DA) and explored whether providers’ beliefs and interest in use of a DA was 
associated with offering PSA tests for early detection of prostate cancer. It was explained that 
DAs are tools intended to help people weigh the benefits and harms of a health decision. In one 
controlled trial conducted, the authors found that providing patients a DA without a personal 
conversation and clinical encounter resulted in greater likelihood of a patients having a PSA test 
without improved knowledge of the test or the potential benefits and harms of their decision. 
This is then defeating the purpose of a DA. When a NP has receptivity towards tools or Das, they 
can assist in and supplement conversations about PSA testing. Currently only 11% of providers 
use a DAs when discussing PSA testing with patients while 54% of providers currently do not 
use DAs but are interested in learning about incorporating a DA into their practice (Rim, et al., 
2018).  
 Allen, Filson, & Berry, (2020) piloted an online DA in primary care settings. The goal 
was to determine the impact of an online DA on patients’ ability to engage in SDM about 
prostate cancer screening. Barriers were identified that deterred fully engaging patients in SDM 
such as the short duration of medical appointments and the need to prioritize a range of health 
  24 
 
concerns. Allen, Filson, & Berry (2020), completed a meta-analysis and systemic reviews that 
demonstrated that DAs can effectively increase patients’ knowledge about prostate cancer 
screening, promote confidence in the ability to engage in decision-making with one’s provider 
and decrease decisional conflict. One goal of this EBP is to promote confidence in shared 
decision making, this article shows that a DA can increase one’s confidence. The online DA that 
was developed for the Allen et al. (2020) study, provided men with the knowledge and skills to 
participate in SDM about PSA testing with their providers. At completion of this study the mean 
average of individuals who felt that the DA prepared them “very well/well” for the conversation 
about SDM with their provider were 89.5%.  
Owens, Wooten, & Tavakoli, (2019) evaluated the use of psychometric properties of 
computer based prostate cancer screening DAs. The article discussed that for African American 
men to make informed decisions they need prostate cancer knowledge to be explained in plain 
language. It was shown that self-efficacy, computer anxiety and attitude towards technology did 
not correlate with technology acceptance or use. The article determined that the computer-based 
decision aid acceptance scale showed potential as playing a key role in increasing prostate cancer 
knowledge and assisting in informed decision making among African American men. One can 
conclude from the literature that the use of a DA can increase knowledge and decision making.   
Allen et al. (2019), explained that many national studies show that many patients do not 
experience SDM in the context of prostate cancer screenings. Shared decision making is often 
difficult to accomplish in clinical practice due to the short duration of clinical visits, the need to 
address competing health priorities and communication challenges between patients and 
providers (Allen et al., 2019). Decision aids are promising means to prepare men to engage in 
SDM that can often occur prior to the appointment. Principle findings showed that DAs are an 
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effective intervention to complement patient/provider engagement in SDM by providing patients 
with information needed to assess their options and examine their values (Allen et al., 2019).  
Stacey et al. (2012), explored the characteristics and effectiveness of decision coaching 
and the use of patient DAs. Decision coaching along with the use of a DA shows improvement in 
knowledge and participation in decision making without reported dissatisfaction. Two trials that 
used both decision coaching and a DA showed improved patient knowledge and treatment 
options for individuals with schizophrenia and women considering breast cancer genetic testing. 
Articles that also used coaching along with DAs compared to usual care had higher perceived 
participation in decision making. The use of a DA and decision coaching can improve both 
knowledge and participation in the decision-making process (Stacey et al., 2012). This is useful 
information seeing that this EBP is measuring both improved knowledge and confidence is 
decision making.  
Synthesis of the Whole 
The review of literature that has been completed for this evidence-based proposal 
provides great evidence to support the use of a decision aid with a community health worker or 
health coach improves knowledge, satisfaction, and confidence. The three themes identified in 
the research positively influence the PICOT question. The articles that were reviewed for this 
proposal touched base on more than one option to improve knowledge, satisfaction, or 
confidence. Community health workers or health coaching and motivational interviewing have 
also shown to improve knowledge and communication (Alizadeh-Sabeg et al., 2021; Brandford 
et al., 2018; Portillo, Vasquez & Brown, 2020). Roland et al., 2017 recognized that community 
health workers lead to positive outcomes related to completion of cancer screenings (RR = 1.35, 
95% CI: 0.95–1.92). A nurse practitioner would make an ideal community health worker or 
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health coach because they hold trust with the community. Generally, nurse practitioners spend 
more quality time with patients and patients feel that nurse practitioners listen to their concerns. 
These feelings and relationships that the patients have towards the nurse practitioners can 
improve satisfaction. 
Research has proven that the use of a decision aid will improve knowledge and leads to 
better communication and improvement in SDM (Allen et al., 2019; Allen, Filson & Berry, 
2020; Owens et al., 2018; Owens, Wooten & Tavakoli, 2019). The use of a decision aid can also 
lead to better informed decisions regarding PSA screening (Allen er al., 2019). This is important 
because informed decisions lead to an improvement in confidence in decision Stamm et al., 2017 
proved that there are better outcomes when shared decision making and a decision aid are used 
together when compared to usual care (72% DA, 78% DA + SDM, 87% UC, p = 0.0285). Stacey 
et al. (2012), was one specific article that compared the use of a decision aid alone, the use of 
community health worker alone, as well as the combination of both the decision aid and usual 
care. The use of a decision aid and community health worker working together improved 
knowledge (15.0 v. 10.9; P = 0.01), participation (COMRADE 79.5 v. 69.7; P = 0.03), and 
satisfaction (odds ratio 1.49; 95% confidence interval, 1.11–2.01; P = 0.008) compared to usual 
care.  This evidence showed that the use of both a decision aid and community health worker 
will meet all the requirements that were identified in the PICOT question. Unfortunately, there 
has not been a significant amount of research done supporting the use of SDM, DAs and CHWs 
regarding prostate cancer and protective service occupations.  This evidence-based proposal will 
provide more information regarding individuals in protective service occupations at risk of 
prostate cancer and the use of a decision aid, community health workers (the NP for the purposes 
of this EBP) and shared decision making.  
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Proposed Clinical Change 
A thorough analysis and review of literature was completed. It was determined that the 
combination of a decision aid and community health worker, such as a nurse practitioner are both 
appropriate and successful methods to improve knowledge of prostate cancer, confidence in 
shared decision making for prostate cancer screening and patient satisfaction. Research has 
shown that individuals in protective service occupations have an increased risk of being 
diagnosed with prostate cancer. Research has also proven that with the change that the USPSTF 
completed regarding PSA and the decision to test for PSA being put directly on the patient there 
have been less providers participating in shared decision making.  
In this EBP we will determine the impact that a Nurse Practitioner led decision coaching 
program will have on individuals who are in protective service occupations such as improved 
knowledge on prostate cancer, increased confidence in decision making and improved 
satisfaction. The goal of the nurse practitioner led decision coaching using a DA will be to 
improve knowledge of prostate cancer, confidence in shared decision making for prostate cancer 
screening and patient satisfaction. Knowledge of prostate cancer, confidence in shared decision 
making for prostate cancer screening and patient satisfaction will be completed during the 
decision coaching session and the decision aid that will be given out in the waiting room while 
the patient waits for the decision coaching to begin. During the decision coaching session, the 
nurse practitioner will educate on where the prostate is located, what prostate cancer is, risk 
factors, signs and symptoms of prostate cancer, secondary prevention measures and the risks of 
the PSA testing. The nurse practitioner will also review the patients specific risk factors. During 
this session the patient will be allotted time to ask about questions or concerns about anything 
they learned about prostate cancer, PSA testing or any other questions they have regarding their 
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health related to their prostate. At the completion of the decision coaching session the patient 
will be asked if they would like to proceed with PSA testing.  
Summary  
A synthesis of evidence provides an inclusive summary of the findings from the 
literature. Three distinctive themes emerged that demonstrate the value of DAs to improve 
knowledge. The use of health coaching and motivational interviewing improves knowledge and 
communication. In chapter one it was discussed that the USPSTF recommended SDM regarding 
PSA testing and the literature did show that SDM provided better results in communication. As 
this evidence-based proposal moves forward further detail will be provided concerning guidance 
for implementation of the intervention and well as the various factors that will facilitate and 
impact the change.  
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Chapter Three: Framework 
To support and strengthen this evidence-based proposal, a nursing theoretical framework 
and EBP model will be used. The nursing theory chosen to guide the proposal is the Health 
Promotion Model (Pender, 1982). The EBP model that will be applied is the Stetler Model 
(1976). The Stetler Model will guide the research methods and plan for implementation of this 
research. Both the framework and EBP model will be used congruently in this research proposal.  
Theoretical Framework  
Nola Pender developed the Health Promotion Model in 1982, which was later revised in 
1996 (Sitzman & Eichelberger, 2017).  Pender’s Health Promotion Model is a high middle-range 
theory. Pender’s Health Promotion Model believed that professionals intervened only after 
people developed an acute or chronic disease and experienced compromised lives (Sitzman & 
Eichelberger, 2017). Pender felt that this was not a proactive stance on health promotion and 
disease prevention (Sitzman & Eichelberger, 2017). Health professionals have multiple 
opportunities to encourage health-promoting behaviors related to presenting concerns and 
anticipated health challenges (Sitzman & Eichelberger, 2017). When using Pender's Health 
Promotion Model regarding this proposal it is using the idea that health professionals such as 
nurses or nurse practitioners are an important tool for educating males in protective service 
occupations positions on improved knowledge of prostate cancer, confidence in shared decision 
making for prostate cancer screening and patient satisfaction.  
Pender’s Health Promotion Model is simple to understand. It begins with an assessment 
by a healthcare professional, specifically gathering data related to behavior, personal factors, 
patient perceptions, and competing demands (Sitzman & Eichelberger, 2017). Then it shifts to 
planning the healthcare professional and the patient will work together to develop a health 
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promotion plan and the patient commits to the plan of action (Sitzman & Eichelberger, 2017). 
The implementation is the incorporation of health-promoting behavior (Sitzman & Eichelberger, 
2017).  Lastly, this will be evaluated based on the actual incorporation of health-promoting 
behavior (Sitzman & Eichelberger, 2017).  
EBP Model 
The EBP Model chosen for this proposal is Stetler Model (1976), this model follows the 
concept of research utilization (RU) (Stetler, 2001). The Stetler Model was developed in 1976 
but later updated in 1994 to reflects a practitioner-oriented approach (Stetler, 2001). There are 
five phases of the Stetler Model, these phases will provide guidance for this proposal. The phases 
are preparation (Phase I) , validation (Phase II), comparative evaluation/decision making (Phase 
III), translation/application (Phase IV) and evaluation (Phase V). The Stetler Model provides a 
clear set of guidelines that are designed to overcome potential barriers to the utilization and 
integration of evidence (Stetler, 2001).  
Application of Framework to EBP Proposal 
The Health Promotion Model (Penders, 1982), along with the phases of the Stetler Model 
(1976) can both be readily applied to this evidence-based proposal. In summary, Pender 
identified multiple factors that would have a potential influence on an individual's health-
promoting behaviors. One factor that correlates with this research is interpersonal influences. 
Interpersonal influences are how significant others around the participant or patient affect 
motivation for positive change (Sitzman & Eichelberger, 2017). In this proposal, the significant 
other is the nurse practitioner. At the end of the research study, the nurse practitioner and the 
patient will be able to identify if the use of a decision aid enhanced knowledge of prostate cancer 
and promoted SDM regarding PSA testing and informed decision making. This will lead to nurse 
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practitioners identifying if the decision aid enhanced education and promoted informed decision 
making with SDM. 
In this proposal, we will be assessing the patient’s knowledge of prostate cancer, 
confidence in shared decision making for prostate cancer screening and patient satisfaction.  The 
nurse practitioner will develop a nurse practitioner led decision coaching program to educate on 
prostate cancer knowledge, secondary prevention measures that enhances informed decision 
making with the use of SDM. We will evaluate that knowledge was increased and that 
confidence in decision making and satisfaction with the communication between the nurse 
practitioner and patients was accomplished. 
The Stetler Model (1976) will be applied to this evidence-based proposal by following 
the phases in correct order. Phase I, which is Preparation, is to identify a priority need. This 
phase been completed when the purpose of the Evidence-based proposal was identified. The 
purpose was identified in the PICOT question and purpose statement. This information can be 
found in Chapter One. Phase II, which is Validation, can be found in Chapter Two as well as 
appendix A. Phase II assess sources of evidence for the level and overall quality of the research 
completed. It is looking to see if the articles have merit and goodness of fit in relation to the 
purpose of the project. A review of literature was conducted to review the relevance of the 
evidence and a matrix was built to assess the quantity and quality of the evidence. Phase III, 
which is Comparative Evaluation/Decision Making, involves summarizing the similarities and 
differences among the sources of evidence that are evaluated. This will then determine if it is 
acceptable and feasible to apply the finding to practice.  This again has been completed in 
Chapter Two, through an extensive synthesis of the evidence and planning for implementation of 
the proposed intervention. Phase IV, Translation/Application, this phase is the development of 
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how to implement the summarized findings and identify practice implications that justify 
application of findings for change (Stetler, 2001). This was identified in Chapter Two in the 
description of the strategy for the proposed change. Phase V, Evaluation, which is the final 
phase. This is the identification of expected outcomes of the project and the determination 
whether the goals of the Evidence-Based Proposal were successfully achieved (Stetler, 2001). 
The evaluation can be formal or informal, as well as individual or institutional (Stetler, 2001). It 
is important to consider cost-benefit of various evaluation efforts and to use research utilization 
as a process to enhance credibility of evaluation data (Stetler, 2001). This phase will be 
discussed in the succeeding chapter, and it will include identification of stakeholders, budgeting 
and cost propositions and proposed plan for implementation.   
Congruence of Framework to EBP Proposal 
The theoretical framework and the EBP model are congruent with the topic of this 
proposal. The Health Promotion Model (1982) coincides with the proposed clinical change due 
to the idea that health care providers only intervened after an acute or chronic problem occurred. 
It places emphasis that health care providers need to be proactive and encourage health-
promoting behaviors such as secondary prevention measures like PSA testing.  
 The Stetler Model (1976) is congruent with this proposal due to its systematic, step by 
step approach to Evidence-Based Proposals. It outlines the necessary steps for the proposal of an 
evidence based clinical change. This occurs by identifying a clinical problem (Phase I), to 
devising a plan for implementation (Phase IV). In the next chapter there will be a more specific 
outline of the Stetler Model (1976) that is specific to this Evidence-Based Proposal.  
Setting 
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The setting in which the proposed nurse practitioner led decision coaching program will 
take place is a primary care office that is in proximity of multiple firehalls and police stations. 
This office is in the city Buffalo, New York and serves many male patients that are employed in 
protective service occupations. The clinicians in this office are two physicians, six primary care 
nurse practitioners and one physician assistant. The population that is primarily served at this 
office is individuals older than 18 years old to end of life. There is a total of nine healthcare 
providers in this office along with many other healthcare professionals such as registered nurses 
and licensed practical nurses. The registered nurses and licensed practical nurses complete all 
laboratory draws that the physicians and nurse practitioners order at that current visit. Without 
leaving the building patients also have access to a walk-in clinic and a pharmacy. The office is 
located near many fire halls, police stations and the district attorney office that employ many 
detectives. The facility serves many protective service occupations. This office does have 
another location located in another section of the city.   
Population 
The population of interest for the proposed clinical change comprises those in protective 
service occupations in an outpatient setting. These individuals will all be male and should be 
over 40 years old but no older than 69 years of age. The population can be easily assessed at  
local police stations, volunteer or paid fire halls or the district attorney’s office which employ 
investigators which is near to the primary care office indicated in our setting.   
System Focus 
It is important to consider all the integral parts of the system that may affect the process 
of the proposed clinical change, or that may be affected by the proposed clinical change. A 
system focus will consider the factors that may be affected by this clinical change. We will 
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examine the small (micro) and large (macro) scale effects that may be impacted by the clinical 
change. Many factors both internal and external play a role in the impact of the proposed clinical 
change.  
Micro/Macro Focus 
When looking at the system with a microfocus lens, we are looking for smaller-scale 
details or components involved. Regarding the proposed clinical change of a Nurse Practitioner 
led shared decision coaching program that utilizes a decision aid on improved knowledge of 
prostate cancer, confidence in shared decision making for prostate cancer screening and patient 
satisfaction, there are many relationships that effect this category. When looking through a micro 
lens the primary relationship to consider is the levels of healthcare delivery. The levels of 
healthcare delivery include the patient and the care team. It is important to think about how the 
proposed clinical change will affect this relationship between the patient and the provider. 
Clinical changes that will occur include educational transaction which will include prostate 
cancer education and PSA testing. Effective teaching with the use of a decision aid will need to 
transpire to improve confidence in shared decision making and patient satisfaction. Another 
clinical change that will occur will be the conversation between the nurse practitioner and patient 
regarding shared decision making about secondary prevention measures such as PSA testing. 
This will transpire during the nurse practitioner shared decision coaching program. The patient’s 
family can be involved during this process if the patient would like them to participate in the 
shared decision process with them.  
When looking at the proposed clinical change with a macro lens, there are many 
interrelationships that may be affected. The macro lens is looking at the bigger picture and the 
entities that may be affected by the change in this EBP. Clinical changes will have an impact on 
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the healthcare system and society. Increasing education with a decision aid and a nurse 
practitioner led shared decision coaching program will increase confidence between patient and 
provider ensuring shared decision making is complete when discussing PSA testing. It will also 
reduce mortality in prostate cancer because patients will have a better understanding of prostate 
cancer and the risks and benefits of PSA testing.  
The impact of the proposed clinical change is multifaceted and has significance across 
the entire healthcare system. Each factor plays a vital role in the healthcare system and society. A 
Nurse Practitioner led shared decision coaching program that utilizes a decision aid on improved 
knowledge of prostate cancer, confidence in shared decision making for prostate cancer 
screening and patient satisfaction yields influential outcomes that can be seen in both micro and 
macro scales.  
Contextual Factors 
There are known contextual factors that can impact the implementation of the proposed 
clinical change. The environment and socioeconomic status of each patient can affect the ability 
to achieve the desired outcomes. A lack of transportation to coaching program would prevent 
patients from receiving a nurse practitioner led shared decision coaching program. The 
population of interest is individuals in protective service occupations, these must hold a high 
school diploma or equivalent. This requirement will ensure that participants with have at least a 
12th grade literacy level. This will be beneficial with the decision aid. Language may impact the 
patient’s ability to understand the decision aid and prevent satisfactory communication between 
patient and nurse practitioner.  
Summary 
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Factors that stem from the implementation of the proposed change are multilayered. It is 
important to evaluate how the clinical change may affect the health system on both a micro and 
macro level. It is established that this clinical change can affect both individuals and system 
levels and are also interconnected. Certain contextual factors may positively or negatively affect 
the implementation of the clinical change. The application of The Health Promotion Model 
(1982) and Stetler Model (1976) both provide support to successfully increase engagement of a 
Nurse Practitioner led shared decision coaching program that utilizes a decision aid on improved 
knowledge of prostate cancer, confidence in shared decision making for prostate cancer 
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Chapter Four: Proposed Clinical Change 
The proposed clinical change, based on the evidence, is to implement a Nurse 
Practitioner led shared decision coaching program that utilizes a decision aid which will improve 
knowledge of prostate cancer, confidence in shared decision making for prostate cancer 
screening and patient satisfaction. These changes are being implemented to improve knowledge 
and shared decision making between a patient and nurse practitioner to help improve knowledge 
regarding PSA testing which will lead to individuals having an informed decision and ensure that 
there is participation between the patient and nurse practitioner in preforming shared decision 
making.  This chapter will discuss the details of the proposed change with an in-depth 
description of the proposed clinical change, implementation, its stakeholders, data collection and 
budgeting. 
Description of Proposed Clinical Change 
The proposed clinical change will first entail recruitment of the participants. Recruitment 
will consist of the nurse practitioner contacting facilities that employ protective service 
occupations such as police stations, firehalls and the district attorney’s office. The nurse 
practitioner will discuss with the leadership in these offices the information about the study and 
asking if it would be alright for flyers to be hung up on a bulletin board at each of the sites. The 
flyer will provide specific information regarding the program and a QR code that individuals will 
scan that will bring them to a short YouTube video (see appendix F). The YouTube video will be 
2-3 minutes in length. The video will provide information on the study such as what the study is, 
who is the targeted population and why it is important to participate in the study (see appendix 
G).  
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At the completion of the YouTube video, the individual will be led to a Google form for 
them to provide their contact information if they are interested in participating in the study. The 
Google form will be created with an email specific to this study. The nurses at the primary care 
office will logged into the email associated with the Google form and will be notified when a 
Google form is completed. After a nurse receives the notification that a form was completed, 
they will contact the individual who completed the Google form and conduct a 4-question 
screening to see if they meet the criteria for the study. If they meet the criteria the nurse will then 
discuss the purpose and design of the study and review the informed consent with the patient.  
Once this is completed the nurse will schedule them for the shared decision coaching session. 
The patient will then be sent a text message by the nurse who reviewed the study and informed 
consent with the patient. The texted link has the informed consent that was reviewed over the 
phone and the pre-questionnaire. The patient will be asked to complete the consent and 
questionnaire (see appendix D) prior to the decision coaching session and to bring them with the 
patient to this decision coaching session for review and processing by the secretary in the office.   
Next is the implementation of a Nurse Practitioner led shared decision coaching with the 
use of a decision aid. The secretary will check the patient in and ensure that the informed consent 
was completed. The secretary will give the patient the decision aid after the check-in process is 
completed. The decision aid, implemented by Massachusetts Department of Public Health (see 
Appendix B) is an in-office decision aid, it has a questionnaire that would be completed right 
before the decision coaching with the nurse practitioner. The questionnaire consists of 6 
questions that would establish if the patient had any risk factors for prostate cancer. It also 
provides frequently asked questions about PSA testing.   
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While waiting for the decision coaching session to begin the patient can complete the 
questionnaire that is attached to the decision aid and read the frequently asked questions on the 
decision aid. This will get the patient thinking about prostate cancer and PSA testing prior to the 
session. The patient will be called to start the nurse practitioner led decision coaching session. 
The nurse practitioner will review the answers of the decision aid questionnaire and assess the 
patient’s risk of being diagnosed with prostate cancer. The conversation will consist of prostate 
cancer education, secondary prevention measures specifically PSA testing, any concerns he may 
have about PSA testing, along with the patient’s personal risk factors such as family history, 
ethnicity and occupational or volunteer hazards. A motivational interview will occur between the 
patient and nurse practitioner allowing the patient to ask any question he has about any of the 
information that was discussed.  
After the completion of the decision coaching session the nurse practitioner will give the 
patient the post-questionnaire (see appendix D) to evaluate their knowledge of what was 
discussed during the decision coaching. Once the patient has completed the post-questionnaire 
the nurse practitioner will review the questions that he has gotten wrong and answer any 
outstanding questions.  This is to ensure that the patient will make an informed decision 
regarding PSA testing. If the patient decides to participate in PSA testing the nurse practitioner 
will put in the order for the nurses to draw the lab work. Prior to the nurse practitioner leaving 
the room after a decision was made about PSA testing, they will give the patient the COMRADE 
tool (see appendix C).  
While the patient is waiting for the nurse to draw blood, he will have time to complete 
COMRADE tool (see appendix C). The COMRADE tool consists of two questionnaires that 
evaluate satisfaction with communication and confidence in decision making. If the patient 
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decides against PSA testing, he will be able to complete the COMRADE tool prior to check out. 
After, the nurse completes the lab work the patient will be directed to the front desk where the 
secretary will then check them out and the patient will give the secretary his completed 
COMRADE tool as well as the post-questionnaire. The secretary will place the tool in their 
chart.  
Once the PSA test has resulted in the patient’s chart, the nurse practitioner will contact 
the patient and advise them on where to go based on the results. Individuals that do have an 
elevated PSA greater than 4ng/ml will be referred to a urologist that will be associated with this 
research. Individuals with a PSA greater than 2.5ng/ml should have their PSA tested on a yearly 
basis; they will be asked if they would like to schedule that appointment at this time. Those with 
a PSA less than 2.5ng/ml will need to be retested in two years unless symptoms of prostate 
cancer occur. If this happens the patients are advised to contact the office for testing.  
Data will be tracked with the data tracking sheet (see appendix J). Information that will 
be tracked includes if the patient decided to have PSA testing done, if they were referred to 
urology depending on their PSA level and if they followed-up with the urologist. The nurse 
practitioner will oversee completing the tracking sheet.  
Stakeholders 
 To successfully implement any clinical change, it is important to identify all probable 
stakeholders who may be impacted by the clinical change. There are many stakeholders that has 
been identified both internal and external to the primary care office setting. The primary 
stakeholders involved in this clinical change are the nurse practitioner and the patient. The nurse 
practitioner’s will be leading the decision coaching and participating in the shared decision 
making. The patient will actively be participating with the decision aid and the decision coaching 
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sessions. They will complete the decision coaching by making an informed decision on if they 
would like to proceed with PSA testing. Nurses will be playing the role of screening patients 
prior to making their appointment to establish if they qualify for the study.  Other stakeholders 
that will be impacted by the clinical change include secretarial staff, family members, 
videography, IT, analyst, urologist, and insurance companies and possibly the employers 
depending on if the patient is in a paid protective service occupation or volunteer.  
Roles 
When implementing a change in clinical practice, it is important to establish and 
designate roles that each member will fulfill to complete the desired clinical goal. The primary 
role of the nurse practitioner will be to lead the decision coaching session and provide 
knowledge to the patient on anatomy and function of the prostate, risk factors of developing 
prostate cancer, prostate cancer screening, prostate cancer symptoms and evaluate their specific 
risk of developing prostate cancer.  The nurse practitioner will also need to answer all questions 
that the patient may have regarding prostate cancer and PSA testing. It is important that the 
conversation leads to informed decision making and shared decision-making regarding PSA 
testing, this conversation will be a motivational interview. The nurse practitioner will also review 
the answers of the post-questionnaire with the patient after they complete it. Following the 
results of PSA testing the nurse practitioner will also oversee contacting the patient with their 
results and advising them on the correct course from there. The nurse practitioner will also need 
to complete the data tracking sheet (see appendix J).  
The role of the nursing staff will be to continuously check to see if there are notifications 
from the Google forms of individuals interested in participating in the study. They will then 
contact the patient after they give their contact information after the YouTube video. During the 
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initial conversation between the patient and the nurse, the nurse will screen the patient to make 
sure that they meet the study criteria and document the answers in the patient’s chart. The nurse 
will then discuss the purpose and design of the study, will read, and review the informed consent. 
Once this is completed the nurse will set up an appointment for the decision coaching session 
and then send the patient via text message the informed consent and pre-questionnaire (see 
Appendix D). The nursing staff will also have the role of drawing the PSA test if the patient 
decides to have secondary prevention measures done.  
Secretarial staff will have multiple different roles. They will first oversee checking the 
patient in and ensuring that the informed consent was completed. After confirmation that the 
informed consent is completed, the secretary will give the patient the decision aid (see Appendix 
B) to be read and completed prior to the NP visit. The patient will hold onto the decision aid until 
they are seen for decision coaching. At the end of the visit the secretarial staff will collect the 
COMRADE scale (Appendix C) and the post-questionnaire (see Appendix D).  
The role of the videographer will create a 2–3-minute YouTube video that describes the 
purpose of the study and who qualifies to participate in the study. The IT department has the role 
to create a QR code that will be on the flyer that is handed out at different protective service 
employee places of work. The QR code will direct whoever is scanning it to the YouTube Video. 
They will also set up the google form with an email that will be associated for with the study.  
An analyst is needed to analyze the results of the pre- and post-questionnaire, 
COMRADE tool and the number of patients that did vs. those that did not decide on following 
through with PSA testing. This information can be found on the data tracking sheet (see 
appendix J).   
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The role of the urologist will be to be on standby for patients that do have an elevated 
PSA and need to be referred to urology. The nurse practitioner will refer patients to the urologist 
who have an elevated PSA testing. The nurse practitioner will keep track of this data on the 
tracking sheet (see appendix J). The nurse practitioner will also be tracking if the patient attended 
the appointment with the urologist.  
Insurance companies will also be affected both positively and negatively. If an individual 
is diagnosed with prostate cancer in a timely fashion treatment option may not be as serious as a 
prostatectomy or radical prostatectomy. Instead, radiation can be a treatment option which would 
be less invasive and more inexpensive than the surgical options. This will affect the insurance 
companies in a positive way. The insurance companies will be billed for nurse practitioner led 
decision coaching. It will be billed as a nurse practitioner visit. This will negatively affect the 
insurance companies since they will need to pay for the visits.   
Step by Step Description 
Stetler’s Phases of Evidence-Based Practice 
Phase One: Preparation.  
The need of this evidence-based proposal was acknowledged by conducting preliminary 
research on the topic. It was identified that protective service occupations are at a higher risk of 
being diagnosed with prostate cancer. It was also noted that when USPSTF identified that 
informed decision making, and shared decision making should occur when discussing and 
deciding on going through with PSA testing, providers were not bringing up the topic of PSA 
testing with their patients. Research has shown that the use of decision aids, health coaching and 
shared decision making positively influence informed decision making regarding secondary 
prevention measures such as PSA testing. To shape the purpose of the project, a PICOT question 
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was formed: “Among protective service occupations, what is the impact of a Nurse Practitioner 
led shared decision coaching program that utilizes a decision aid on improved knowledge of 
prostate cancer, confidence in shared decision making for prostate cancer screening and patient 
satisfaction over 12 weeks?”. Measurable outcomes that were identified were improved 
knowledge of prostate cancer, confidence in shared decision making and patient satisfaction. 
Phase Two: Validation. 
 A thorough review of the relevant and available literature published within the last two 
years except for two articles that we published in 2015 and 2012. The literature review was 
conducted to gather credible evidence for this proposal. Multiple search strategies and databases 
were used to compose the literature that was reviewed for this proposal. A matrix of literature 
was completed to analyze the strengths, weaknesses, and similarities of each study and to 
appraise the evidence (see Appendix A).  
Phase Three: Comparative Evaluation/Decision Making.  
 Once the findings had been summarized and organized in the matrix (see Appendix A), a 
full synthesis of the evidence was conducted. From there three themes emerged: 1) Shared 
Decision Making; 2) Community Health Workers and Motivational Interviewing; and 3) The 
Use of a Decision Aid. The use of  a decision coach and decision aid was proven to improve 
knowledge along with improving communication and satisfaction. Based on the findings a 
decision was made to put this evidence-based knowledge into effect and move forward with the 
proposal.  
Phase Four: Translation/Application.  
 Once the evidence-based intervention was determined, a plan for implementation in a 
primary care setting was constructed. The application of proposed change was described earlier 
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in this chapter. The proposed change included identifying the relevant stakeholders, their roles, 
and responsibilities, and how the change will be interpreted into the workflow or clinical change.  
Adequate education for all stake holders will be necessary and a formal education session will be 
provided.   
Phase Five: Evaluation.  
 To evaluate the success of the clinical change, various anticipated outcomes will be 
clarified. We will evaluate the knowledge with a pre- and post- questionnaire (see Appendix D) 
to establish if each patient benefitted from the decision coaching. This pre- and post- 
questionnaire was used in Owens et al, (2018) article. This EBP uses the COMRADE tool to 
evaluate satisfaction and confidence with decision making (Appendix C) (Edwards et al., 2003). 
A cost-benefit analysis will be conducted to evaluate the feasibility of the proposed clinical 
change. The data collection and analysis procedures and the cost benefit analysis process will be 
outlined in further detail in the chapter.  
Workflow and Responsibilities 
 For this proposed clinical change to occur, a few alterations in the workflow be 
implemented. To recruit patients for this clinical change, the recruiting process will be completed 
by nurse practitioners. The nurse practitioners will contact firehalls, local police stations and the 
district attorney’s office. The nurse practitioner will speak to either the individual in charge and 
will explain the study that will be conducted and seek permission to hang up flyers on bulletin 
boards. Once permission is received the nurse practitioner will go to these sites to hang up the 
flyers. The nurse practitioner and IT department will team up to create a flyer (see Appendix F) 
that contains information about the study and a QR code that will scan and bring up a YouTube 
video that will provide information about the study. 
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The responsibilities for IT include developing a QR code for the informative flyer (see 
Appendix F) and creating a function that after the YouTube is completed the webpage is 
redirected to a Google form to fill out contact information that will be sent to the primary care 
office for those who are interested in participating in the study. The IT department will also 
oversee setting up the google form with the email associated with the study.  The videographer 
will work with the nurse practitioner to create the short 2–3-minute YouTube video about the 
study. The responsibility of the videographer is to create the YouTube video that is informative 
to the viewer. The information contained in the YouTube video will be who is at risk for prostate 
cancer, what this study is, and the criteria needed to be met to participate in the study. At the 
completion of the video the IT tech will set up the video to automatically open a Google form for 
the individual watching the video. The Google form will allow them to input their name and 
contact number if they would like to participate in the study. The Google form will be created 
under an email that is specific for this study. Once the patient inputs their contact information 
and submits the information, a notification will be sent to the specific email that is monitored by 
the nursing staff at the primary care office.   
 The nursing staff has a plethora on responsibilities in this clinical change that occur in 
different times during the change. The screening questions will include age, gender, occupation, 
and previous diagnosis of prostate cancer. The criteria that would allow the individual to 
participate in the study would be age greater than 40 years old, male, no previous diagnosis of 
prostate cancer and protective service occupation. The nurse will document this information in 
the patient’s chart. Once the nurse verifies that the individual calling meets the criteria the nurse 
will explain the purpose and design of the study and to read and explain the informed consent to 
the patient. If the patient wishes to continue the nurse will be responsible for scheduling them for 
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the nurse practitioner led decision coaching session. Once the appointment is scheduled the nurse 
will send the informed consent and pre-questionnaire via text to the patient to complete prior to 
the decision coaching session. Later in the clinical change the nurse will be responsible for 
checking the patient’s chart to see if the nurse practitioner ordered PSA testing, if the nurse 
practitioner did order PSA testing the nurse will be responsible for going to the patient’s room 
and drawing the blood for the test.   
Once the patient arrives at the office for the nurse practitioner led decision coaching 
session, the patient will be checked in with the secretarial staff. The staff will be expected to 
check in the patient in a timely manner and ensure that the patient has completed the informed 
consent. Once it is established that the patient has completed the informed consent and the 
patient is checked in the secretary will give the patient the decision aid (see Appendix B). The 
decision aid offers education or frequently asked questions regarding prostate cancer. The 
decision aid also has six questions that the patient will fill out. The questions specifically address 
the patient’s individual risk for developing prostate cancer. The patient will hold onto the 
decision aid until the coaching session begins with the nurse practitioner. The responsibilities of 
the secretarial staff include checking the patient in, printing all documentation such as decision 
aids and questionnaires, making sure all documents have associated number to the patient to 
maintain confidentiality, keeping track of questionnaires ensuring that are completed. The 
competed questionnaires are needed to analyze the results of the study. The secretarial staff will 
also check the patient out and ensure that the patient’s chart has the correct contact information.  
Once the patient is checked in and the decision aid is completed the patient will be called 
into a room to begin the NP led decision coaching session. Since the nurse practitioner is one of 
the primary stakeholders in this clinical change, they have many responsibilities. The nurse 
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practitioner’s responsibilities include ensuring that the NP is properly educated on what they 
need to educate the patient on such as prostate cancer knowledge, risk factors, symptoms, or 
secondary prevention measures. This is important because the nurse practitioner will be 
educating the patients on this information. Other responsibilities include actively encouraging the 
patient to participate in the conversation and encouraging the patient to participate in the shared 
decision-making regarding PSA testing. This will happen in a back-and-forth conversation and 
will be considered the motivational interviewing. The nurse practitioner will also oversee the 
ordering of PSA lab test if that is what both the patient and they decided on. The nurse 
practitioner is also responsible for reviewing answers to the post-question to ensure that the 
patient understands all the information that was discussed in the session. Later in the clinical 
change, the nurse practitioner will be responsible for contacting the patient and discussing results 
of the PSA test. Depending on the PSA test results, the nurse practitioner will then suggest the 
next steps for the patient whether that be referring them to a urologist or scheduling another 
appointment to see the patient.  
The nurse practitioner will take on the role as a decision coach which will be different 
from their role as a nurse practitioner. In this clinical change the nurse practitioner will lead one 
on one decision coaching appointments with each patient. Topics of conversation that the nurse 
practitioner will discuss during the decision coaching will include the anatomy and function of 
the prostate, symptoms that correlate with prostate cancer, screening measures and risk factors. 
The nurse practitioner will also discuss each patient’s specific risk factors of developing prostate 
cancer. These risks were established when the patient answered the 6 questions on the decision 
aid (see Appendix B) that was given by the secretarial staff.  The patient will ask all questions 
that they may have regrading prostate cancer knowledge, risk factors, symptoms, or secondary 
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prevention measures. With the patient being able to ask the nurse practitioner questions 
regarding PSA testing and risk factors for developing prostate cancer this leads to informed 
decision making. At the end of the decision coaching session the nurse practitioner will give the 
post-questionnaire for the patient to complete. Once completed the nurse practitioner will go into 
the patient’s room to review the answers of the post-questionnaire (see appendix D). This is 
important as the patient should understand the correct answers and rationale as to why they are 
the correct answers. Having the correct information should allow for the patient to make an 
informed decision regarding PSA testing.  
Once the questionnaire has been reviewed and the patient has a better understanding of 
everything that was discussed in the nurse practitioner led decision coaching session the nurse 
practitioner and patient will use shared decision making to decide if the patient should through 
with PSA testing. The patient will need to give the nurse practitioner a yes or no regarding 
testing for PSA at this visit. The nurse practitioner will record their answer in the data tracking 
sheet (see appendix J). If the patient does decide to follow through with getting PSA testing done 
the nurse practitioner will order the PSA test. Before leaving the room, the nurse practitioner will 
give the COMRADE tool (see Appendix C), the patient will have time to complete the tool while 
they wait for the nursing staff to come in and draw blood or before they leave if they have 
decided not to complete the PSA test.  
Once the order for the PSA test has been placed, the nursing staff will get a notification 
for a blood draw. The nurse will gather materials and head to the patient’s room to draw the lab 
work. Once the nurse is done obtaining the blood work, and the COMRADE tool is complete the 
patient will be directed to bring paperwork to the front desk and check out. The patient will turn 
the completed questionnaire and COMRADE tool to the secretary. The secretary will place the 
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questionnaire and COMRADE tool in the designated folder. Once the patient is checked out, the 
nurse practitioner led decision coaching session is completed.  
After the completion of the decision coaching session, the data tracking and analysis will 
begin. The responsibility of the analyst is to transcribe and evaluate all the data that was 
collected. The data includes screening information that included demographics, the pre- and 
post-questionnaire, the COMRADE tool, and those who followed through with PSA testing.   
While the data is being analyzed, the nurse practitioner will be checking for results of the 
PSA for the patients. One the PSA test has resulted the nurse practitioner will contact the patient 
to review their results. Based on the results, the nurse practitioner will decide on the plan for  
follow-up. The nurse practitioner will follow these guidelines for deciding follow-up. Those with 
a PSA less than 2.5ng/ml will need to be retested in two years unless symptoms of prostate 
cancer occur. The nurse practitioner will encourage the patient to schedule an appointment in one 
year for a yearly physical. If the patient is willing the nurse practitioner will schedule that 
appointment while on the phone with the patient. Those with a PSA greater than 2.5ng/ml should 
have their PSA tested on a yearly basis. They will also be asked if they would like to schedule 
that appointment at this time.  For patients with an elevated PSA greater than 4ng/ml, they will 
be referred to a urologist.   
There will be an active urologist that will accept transferring of patients with an elevated 
PSA greater than 4ng/ml. The responsibility of the urologist will be to take over care of the 
patient with the elevated PSA and continue diagnostic tests to establish the diagnosis of prostate 
cancer. The nurse practitioner will make a note in the patients charts who are transferred to 
urology and follow up with them in 1 month to evaluate if they attended the appointment with 
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the urologist. Patients that were transferred to urology and the one month follow up will be 
tracked on the data tracking sheet (see appendix J) by the nurse practitioner.  
Education Plan 
 An organized educational plan is required for successful implementation of the proposed 
clinical change. Education will first occur with secretarial staff, nursing staff and the nurse 
practitioners. After that occurs, education must take place with the patients and other 
stakeholders.  
 Education for the secretarial staff, nursing staff, and nurse practitioners is essential for 
implementation of the proposed clinical change. The secretarial staff must be educated on the 
data collection process and proper location to place completed post-questionnaires and 
completed COMRADE tools. The nursing staff will have extensive education on contacting the 
patient and understanding the screening questions that must be answered to evaluate if a patient 
can participate in the study. The nursing staff will also be educated that they need to specify what 
the informed consent entails and review it with the patient. They will also be educated on how to 
send the informed consent and pre-questionnaire to the patient once it has been established that 
they meet the criteria to participate in the study. Appendix H has education materials for the staff 
and specifically the nurses who will be involved in the EBP (see appendix H). Scheduling 
appointments and obtaining laboratory blood draws is already part of the nursing staff job 
description. Extra education is not required for those two areas.  
Education for the nurse practitioner is essential since they are the primary stakeholder in 
this clinical change. The nurse practitioner must be agreeable to the decision coaching sessions 
and be educated on the use of a decision aid to improve prostate cancer knowledge, and shared 
decision making between them and the patient. The nurse practitioners must also be educated on 
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prostate cancer and the decision coaching program. Appendix I has the educational materials and 
plan for the nurse practitioner. 
The second phase of the education plan will include providing patients with educational 
materials. The decision aid (see Appendix B) that was given at the beginning of the appointment 
contains information about PSA testing and frequently asked questions regarding PSA testing.  
Desired Outcomes 
 The aim of the proposed clinical change is to increase the knowledge of prostate cancer 
for protective service occupations and improved satisfaction with shared decision making and 
improved confidence in decision making regarding PSA testing. The success of these outcomes 
will be measured via the collection of data from a pre- and post- intervention questionnaire that 
will assess the level of knowledge. The COMRADE questionnaire will measure both improved 
satisfaction and improved confidence. The desired outcomes of this evidence-based proposal are 
increased shared decision making with prostate cancer screening in protective service 
occupations. This will be tracked using the COMRADE tool. The COMRADE tool will track the 
satisfaction in the conversation and confidence in decision making. All patients will complete 
this after the nurse practitioner led decision coaching. Multiple studies indicated that a use of a 
decision aid and community health workers can produce these outcomes (Alizadeh-Sabeg et al., 
2021; Brandford et al., 2018; Portillo, Vasquez & Brown, 2020).  
Data Collection  
 A plan for data collection is necessary to ensure that outcomes of the clinical change can 
be properly evaluated.  
Knowledge. Collecting data before the intervention then after can illuminate the overall 
success in improving knowledge about prostate cancer, satisfaction, and confidence. Data 
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collection methods include a pre- and post-questionnaire (see Appendix D) that will be given to 
individuals before their decision coaching session. Willingness to participate in the study will be 
expressed upon the patient attending to scheduled appointment. The pre-questionnaire will be 
sent via text message along with the informed consent. This will be sent by the nurse after the 
nurse discuss the purpose and design of the study and reviews what the informed consent entails 
with the patient. Upon arrival the patient will check in with the secretary and the secretary will 
confirm an informed consent was completed. Once this occurs the secretary will give the patient 
the decision aid to read over and complete while waiting for the nurse practitioner led decision 
coaching session to begin. The patient will be escorted to a room and will complete the decision 
coaching session. At completion of the decision coaching session the patient will be given the 
post-questionnaire to complete. Once completed the nurse practitioner will review the answers 
with the patient to ensure all questions were answered correctly and that the patient understands 
all the information. The patient will then be asked to decide if they would like to follow through 
with PSA testing.  
Satisfaction and confidence. After a decision is made the nurse practitioner order the PSA 
test and will then give the patient the COMRADE tool to fill out. After the nurses have 
completed the PSA testing, the patient will then return the post-questionnaire and COMRADE 
tool to the secretarial staff at check-out.  
Shared Decision making. The tracking tool that will be used to keep track if patients have 
decided on PSA testing and if they needed to be referred to urology and the tracking of patients 
following through with urology will all be tracked on the data tracking tool (see appendix J). The 
nurse practitioner will keep track of this tool and mark yes or no to what patients have decided 
on PSA testing and the follow-up process.  
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All data that is collected will be kept in secure files without identifiable information. All 
paperwork will have a unique number that is associated with that patient. All paperwork will 
have the number on it to avoid personal information such as name or date of birth to remain on 
the paperwork.  
Data Analysis and Evaluation Plan 
Knowledge. Once all the data has been collected, a data analysis will be conducted to 
determine if the intervention was successful or not. Scores on the pre-questionnaire will be 
recorded on a data tracking tool and scores on the post-questionnaires will also be recorded on a 
data tracking tool. Using descriptive statistics, a change in scores will be calculated to determine 
the percentage of improved knowledge resulting from the decision coaching session.  
Satisfaction and confidence. The COMRADE questionnaire will be evaluated for the 
percentage of improved satisfaction and confidence in the patient decision making. The 
COMRADE tool uses the Likert scale to measure a participant’s satisfaction and confidence in 
decision making.  
Shared decision making. Data will also be analyzed to see the percentage of individuals 
who followed through with getting PSA testing done after attending the nurse practitioner led 
decision coaching verse those who did not follow through with PSA testing. This will be tracked 
using the data tracking sheet (see appendix J).  
A descriptive change will be used to determine if there was an association between the 
intervention and improved knowledge of prostate cancer, improved satisfaction and confidence 
in shared decision making for prostate cancer screening. It is anticipated that those who are 
educated with information that they learned in the nurse practitioner decision coaching will score 
better on the post-questionnaire and have higher rates of satisfaction and confidence.  
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Communication Plan 
Communication about the proposed clinical change will ensure proper implementation of 
the process. It is a necessary component to the clinical change. It will be necessary to discuss 
how the clinical change will affect the workflow for all the stakeholders and how it will be 
communicated to everyone. The plan will first start with a brief in-person meeting with 
secretarial staff, nursing staff and nurse practitioners to notify them of changes that will be put in 
place for them. There will be a discussion about the paperwork such as the decision aid that will 
be handed out at check in along with paperwork that will be collected at the completion of the 
appointment. The roles and responsibilities will be communicated for all involved with the 
clinical change. It is important to allow time during the meeting to give staff members time to 
ask questions or give concerns they may have. Contact information will be given to staff if they 
have any more questions or concerns, they can reach out. Additional meetings will be provided 
on an as needed basis to ensure readiness for implementation.  
Once the results of the study have been determined, communication of the results to the 
stakeholders is important. It is important to notify the stakeholders with the results of the study, it 
is important because they need to know what they will need to do to sustain the change. 
Stakeholders such as the nurse practitioners will need to adapt to shared decision making and 
informed decision making to sustain the change. Patients will need to be comfortable with using 
motivational interviewing during the coaching sessions this will help sustain the informed 
decision making and shared decision making. Once the data and results are finalized the 
information will be presented on large graphs and flyers. Graphs and flyers will be presented in 
the front of the office for other patients to see. The results will also be shared with the second 
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office during the monthly meeting with providers. This will help with expansion of the study to 
this site. The results will also be present in the front of the second office as well.  
Timeline 
 The timeline for implementation of the proposed clinical change will be in accordance 
with the five specific phases of the Stetler Model (1976). Below is a table that summarizes the 
timeline for this evidence-based project.  
Step of Project Timeframe 
Phase One: Preparation 2 weeks  
Phase Two: Validation 3 weeks 
Phase Three: Comparative Evaluation/Decision Making 5 weeks 
Phase Four:  
 Translation (communication of the change, 
training, acquiring materials) 
 Application (implementation) 
 
5 weeks  
 
12 weeks 
Phase Five: Evaluation 8 weeks  
Total Time 35 weeks  
 
During phase one a clinical problem was identified, and a clinical question was 
formulated. After two weeks of extensive thorough search of research a formal PICOT question 
was established. Measurable outcomes of the clinical question were considered.  
During phase two a collection of evidence and an extensive review of literature was 
completed. Once this was completed the evidence was placed and organized into a matrix. Three 
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weeks was given for completion of the review of literature and matrix. Once the matrix was 
completed, phase three was able to begin.  
During phase three the evidence that was found in the previous phase was synthesized 
and three themes were transpired. Phase three took five weeks. During the five weeks the best 
evidence was identified. A decision was then made to move forward with the implementation.  
 Phase four is the most extensive phase with two different components of the phase. The 
first component of phase four is translation, five weeks was given for this phase. The second 
component of phase four is application, twelve weeks was allotted for this phase. This will give a 
total of seventeen weeks for phase four. In the five weeks of the transition section introduction of 
the clinical change and preparation. Communication of the clinical change to the stakeholders 
that is outlined in the “Communication Plan” section will also occur during those five weeks. 
Education about the clinical change and its translation into the workflow will occur via in-person 
meetings with staff, along with training sessions. During this five weeks, essential materials such 
as printing of the decision aids and questionnaires that are essential for the implantation phase 
will be obtained.  The following section in phase four, application is when the clinical change 
will be applied. Over the twelve weeks the nurse practitioner will lead decision coaching 
sessions to first responders. Patients will be given the decision aid, pre- and post- questionnaires 
along with the COMRADE forms that need to be completed. Sufficient time is allotted to ensure 
for data collection. At the end of the twelve weeks, no longer data will be completed.  
 The final phase, phase five entails an examination of  the data that was collected. After an 
examination of data, an evaluation of the success of the clinical change is completed. The cost-
effectiveness of the clinical change will also occur during this phase. Once completed the results 
of the clinical change will be communicated with the stakeholders. Communication with the 
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stakeholders is important during this phase to ensure that the changes that occurred will be 
sustained. Anticipating that the results will be beneficial, talk on expanding this study will also 
occur in this phase. Phase five will take a total of eight weeks to be completed.  
Budget 
An assessment of the budget is an important step when considering the implementation of 
the clinical change. The cost will be a major determinant of whether an intervention is feasible or 
not. It is necessary to examine the potential cost to both the primary care office and the patients 
that will be participating. A complete budget table for implementation, with all associated costs 
can be seen in Appendix E.  
Costs that are included in the budget include meeting and presentation preparation, staff 
attendance at meetings and training sessions, materials, videographer, IT, and compensation. Ten 
hours will be allotted to the change leader (nurse practitioner). Included in these 10 hours are 
time to prepare for the staff education meetings, time to prepare for education of recruitment site 
leaders, development of a marketing plan for contacting employers to discuss the study and ask 
for permission to hang up flyers for the study, and time it takes to drive to each location for 
distribution of the flyers. Compensation for travel costs will be at current NYS mileage 
reimbursement.  
Staff will be expected to attend a training session that will be accounted for in the 
organizational costs. Attendees will include the lead physician, two nurse practitioners, one 
physician assistant, one registered nurse, two licensed practical nurses, one office manager and 
two secretaries. Everyone will be trained on the decision aid, pre- and post-questionnaire, and the 
COMRADE tool and how collection procedures will transpire. They will also be informed of 
screening measures that need to be completed during the initial phone call with the patient and 
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locating the informed consent to see if it has been completed or not.  They will also be informed 
on the anticipated outcomes of the clinical change. Salary and estimated wages have been 
estimated using ziprecruiter.com for the geographical region. Material costs will cover patient 
resources and data collection tools (see Appendix B, C, D) along with the recruitment flyer (see 
Appendix F) and a brief educational sheet for staff.  
Lastly, it is important to understand the costs which may be incurred by the patient. 
These costs are highly variable as each patient’s insurance situation varies. It is presumed that 
most patients will have insurance seeing that they are occupied in protective service occupations, 
but everyone’s financial situation is different. Direct costs that may occur include visit copays 
and the cost of a lab draw. It is presumed that this will all be covered under the patient’s 
insurance.  
Return on Investment 
Return on investment is an important factor to consider with the implantation of any 
clinical change (see appendix E). In this specific study there is a great gain on the return of 
investment. The nurse practitioner led decision coaching session will be billable hours which will 
improve the return on investment. The program itself will bring more patients into the primary 
care setting thus leading to more yearly physicals, sick visits etc. All these appointments will be 
billable hours and return on investment. Insurance companies will also see a return on 
investment with having less invasive procedures such as radiation verses a radical prostatectomy. 
The COMRADE tool that is part of the clinical change that measures satisfaction. The 
goal is to have improved satisfaction at the conclusion of the study. Improved satisfaction will 
benefit the office by word of mouth. If the participates are satisfied with the experience they had 
during the study, they will refer their friends to become patients at the facility. This will increase 
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profit related to an increase in patients. In this case, the primary care office will not lose money 
due to the implementation of the clinical change.   
Summary 
 This chapter discussed putting the clinical change into motion. Stakeholders and their 
roles were discussed along with the education plan that needs to be in place to educate everyone 
on the clinical change. There were other factors that determine if an implementation of a new 
clinical change is feasible. The budget was discussed along with the return on investment that 
shows that this clinical change is feasible and that the clinical change will not negatively affect 
the primary care office.  
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Chapter Five: Conclusions 
 Evidence-based practice guides clinical changes that better communication for patient-
care delivery. When implementing an evidence-based intervention, it is important to observe the 
potential impact that the change could have on the healthcare system. The anticipated outcomes 
should be assessed to consider the risks and benefits of implementing the change in the current 
primary care practice. The aim of this evidence-based project is to develop a program to increase 
knowledge in protective service occupation individuals about prostate cancer and PSA testing, 
along with improving satisfaction with shared decision making and confidence in informed 
decision making in a primary care setting.  
Potential Impact 
The implication of this evidence-based proposal in a primary care setting has the 
potential to impact many aspects of the health care system. Those affected by the change will 
include patients and nurse practitioners. Patients will have an improved knowledge of prostate 
cancer and secondary prevention measures. This proposal will lead to improved shared decision 
making between the nurse practitioner and the patient, this will change how providers and 
patients decide on PSA screening. With the early and appropriate prostate cancer screening we 
will have earlier identification of prostate cancer leading to earlier and less invasive treatment 
options. With less invasive treatment options, the patient should maintain a better quality of life 
and costs of care will be contained for both the insurance companies and the patients.   
The impact that this evidence-based proposal will have on the nurse practitioner will 
include improved communication skills with patients. The improved communication skills will 
cross over to other patients that the nurse practitioner is treating. This will improve overall rating 
at the primary care office and lead to more individuals wanting to become patients at that office.  
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Anticipated Outcomes 
With the implementation of this evidence-based proposal, the main anticipated outcome 
is improved knowledge of prostate cancer, along with improved satisfaction and confidence in 
shared decision-making regarding PSA testing. The evidence provided indicates that the decision 
coaching and the use of a decision aid can improve knowledge, satisfaction, and confidence. 
Based on literature, it is predicted that the use of a decision aid and community health worker 
working together improved knowledge (15.0 v. 10.9; P = 0.01), participation (COMRADE 79.5 
v. 69.7; P = 0.03), and satisfaction (odds ratio 1.49; 95% confidence interval, 1.11–2.01; P = 
0.008) compared to usual care (Stacey et al., 2012). This EBP proposal utilizes the NP as the 
community health worker and is anticipated to yield similar results.  
Secondary outcomes are also likely to result from this intervention. It is anticipated that 
the patients will be more aware about prostate cancer, secondary prevention measures and 
symptoms related to prostate cancer. Increased awareness will allow for future early 
identification of a potential need for PSA screening. Finally, a secondary outcome may be that 
the patients become more aware of their goals, values, and preferences about secondary 
prevention measures.  
Implications for Practice 
 There are many practice implications highlighted in this evidence-based proposal. The 
first implication is for nurse practitioners to take on a role of providing shared decision making 
and informed decision making regarding prostate cancer and PSA testing. Prostate cancer is the 
most diagnosed cancer in the United States, and it is recommended that PSA testing is based on 
shared decision making and informed decision making between the provider and the patient. The 
nurse practitioner is the most ideal individual to provide the intervention identified in this 
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proposal because nurse practitioners are trusted by the community. Other implications include 
the patient participating in shared decision making and informed decision making. This is 
projected in the decision coaching and reviewing the answers of the post-questionnaire before 
deciding on PSA testing or not. The main goal of this intervention is to help those identified 
establish their risk factors of prostate cancer and identify their desire to follow through with PSA 
testing. 
Sustainability 
 Once the data analysis has been completed and there is a demonstrated improved 
knowledge of prostate cancer, increased satisfaction with shared decision making, and improved 
confidence regarding PSA testing it will be important to expand this program.  This program will 
first expand to other primary care offices. Nurse practitioners will travel to other primary care 
offices that have in house laboratory testing. Education will be provided to all employees and the 
nurse practitioner will stay at the new sites to oversee the beginning of the clinical change and be 
available to answer questions when needed. Once the program has been started flyers will be 
given out to other protective service occupation employers to gather more individuals to 
participate at the new primary care offices. Other locations that employee protective service 
occupations include factories such as General Mills and with the proximity to the Canada Border 
it would be beneficial to reach out to Border Patrol to implement them into the study. Both 
occupations would fall under the protective service occupations and could potentially be at an 
increased risk of developing prostate cancer.  
Future EBP Project/Research 
 With completion of this evidence-based proposal supporting the implementation of a 
nurse practitioner led decision coaching with the use of a decision aid in the primary care setting, 
  64 
 
there may be other areas of inquiry that could benefit from this evidence-based proposal. One 
area of future exploration would be to implement this proposal in other occupations that were 
identified in chapter one as an increased risk of developing prostate cancer including 
management and administration, farming, construction, and transportation (Sritharan et al., 
2019). It would be feasible to identify these individuals in other occupations and bring them into 
the primary care office and establish the nurse practitioner led decision coaching sessions with 
them.  
Another area of future exploration would include completing this research then start a 
qualitative research study with the individuals that participated in this current evidence-based 
proposal. In the qualitative study, there would be in person interviews with the protective service 
occupation participants. Topics of conversation would include how they felt about the program 
and any recommendation they would have about the program. The qualitative research study 
would improve the program and identify any changes that may be needed. Other ideas to expand 
nurse practitioner decision coaching would include provide the decision coaching to other 
diseases that would benefit from the coaching such as breast cancer. It was identified in 
Alizadeh-Sabeg et al (2021) that motivational based coaching increased individuals breast cancer 
screening behaviors.  
Summary 
The purpose of this evidence-based proposal was to examine the effectiveness of nurse 
practitioner led decision coaching using a decision aid to improve knowledge of prostate cancer, 
improved confidence in shared decision making for prostate cancer screening and patient 
satisfaction. After a thorough review and synthesis of the available literature and evidence, it was 
determined that decision coaching with the use of a decision aid were effective to improving 
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knowledge, confidence, and satisfaction. The following clinical question was developed: Among 
persons who are in protective service occupations, what is the impact of a Nurse Practitioner led 
shared decision coaching program that utilizes a decision aid on improved knowledge of 
prostate cancer, confidence in shared decision making for prostate cancer screening and patient 
satisfaction over 12 weeks? To answer this question a clinical change was proposed which 
involved the implementation of a nurse practitioner led decision coaching with the use of a 
decision aid. An extensive plan was discussed for the implementation of the proposed clinical 
change and a thorough evaluation of all components were completed. All components of the 
clinical change were considered with guidance of the nursing theory Health Promotion Model 
(Pender, 1982) in conjunction with the steps of the evidence-based proposal model Stetler Model 
(1976).  A plan was developed for the evaluation of the clinical change, including strategies for 
data collection and analysis. With meaningful data, a decision can be made to move forward with 
incorporating the nurse practitioner led decision coaching with the use of a decision aid into the 
primary care setting with the hopes to improve  knowledge of prostate cancer, confidence in 
shared decision making for prostate cancer screening and patient satisfaction in protective 
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Appendix A: Matrix of Evidence 
Reference Description/ Summary –   Analysis/Evaluation –  
 
Synthesis –  
 
Kim, K., Choi, J. S., Choi, E., Nieman, C. 
L., Joo, J. H., Lin, F. R., Gitlin, L. N., & 
Han, H.-R. (2016). Effects of community-
based health worker interventions to 
improve chronic disease management and 
care among vulnerable populations: A 
systematic review. American Journal of 
Public Health, 106(4). 
https://doi.org/10.2105/ajph.2015.302987  
Main Points: 
 Community-based health 
workers (CBHWs)- public 
health workers who are trusted 
members of the community 
they serve.  
 CBHWs tending to save on 
costs.  
 CBHW interventions are 
effective in promoting a wide 
range of heathy behaviors 
such as breast cancer 
screening, self-management of 
diabetes, hypertension, and 
asthma.  
 
Research Type:  
 Systemic review  
Purpose:  
 Provide a critical review of the 
evidence on CBHW 
interventions. Specifically, 
examining the types of 
interventions in which 
CBHWs are employed, the 
Strengths:  
 30 studies out of 67 
involved CBHWs for 
cancer prevention.   
 
Weaknesses: 
 None of the cancers in 




 most studies focused on 
preventing cancer and 
cardiovascular disease.  
 Touched base on cost 
outcomes with CBHWs 
 Explained qualifications 
and characteristics of 
CBHWs 
 
Light of the Whole 
How relates: 
 CBHWs play an 
essential role in 
bridging between 
the health care 
services and the 
communities 
they serve.  
 
Similar: 
 Describe benefits 
of CBHW.   
 CBHW used in 
collaboration 
with providers.  
Differs: 
 Provided range 
of CBHW with 
multiple disease 
processes.  
Level of Evidence: 
 Level I 
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qualifications and 
characteristics of CBHWs and 
the patient’s outcomes and 
cost effectiveness of such 
interventions in vulnerable 
populations with non-
communicable chronic 
conditions.   
Main Findings: 
 CBHWs delivered a wide 
range of interventions 
including education, 
counseling, navigation 
assistance, case management, 
social services, and social 
support.  
 CBHW interventions were 
performed in collaboration 
with health care professionals.  
 21 out of the 30 CBHW-led 
intervention on cancer control 
found improvements in cancer 
screening behaviors.  
 Positive changes in 
mammogram uptake were 
noted in 9 out of 16 articles.  
 
Conclusions: 
 CBHW interventions were 
effective in promoting CVD 
risk reduction, cancer 
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screening and cognitive 
functioning. 
 CBHWs play an essential role 
in bridging between the health 
care services and the 
communities they serve.  
 Can be an effective 
intervention model that is also 
cost effective for certain 
health conditions 
Owens, O. L., Felder, T., Tavakoli, A. S., 
Revels, A. A., Friedman, D. B., Hughes-
Halbert, C., & Hébert, J. R. (2018). 
Evaluation of a computer-based decision 
aid for promoting informed prostate cancer 
screening decisions among African 
American men: Idecide. American Journal 
of Health Promotion, 33(2), 267–278. 
https://doi.org/10.1177/0890117118786866  
Main Points: 
 PSA test can lead to over 
treatment of indolent PrCA.  
 American cancer society 
(ACS), American urological 
association, and the US 
preventative services task 
force to recommend informed 
decision making (IDM) with 
healthcare provider to 
determine whether to receive 
PSA screening for PrCA or 
not.  
 Informed decision making is 
characterized by a patient 
having a clear understanding 
about the disease, possessing 
knowledge of the risks, 
benefits, and uncertainties of 
screening and subsequent 
treatment, and actively 
engaging in a level of 
decision-making desired. 
Strengths: 
 Study approved by 
institutional review 
board 
 Large Sample size  
 
Weaknesses:  
 Participants resided in 
one location.  
 
Why included: 
 Asked if they have had 
discussion with doctor 
about PrCA before.  
 
 
Light of the Whole: 
How relates: 






 Discussed SDM 
 Computer based 
decision aid.  
 
Differs: 
 Does not 
mention the use 
of iDecide and 
SDM.  
 
Level of Evidence: 
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 Men receiving an IDM 
intervention reported 
significant increase in 
knowledge about PrCA 
compared to control group.  
 
Type:  
 Experimental study.  
 
Purpose:  
 To evaluate the effects of 
iDecide on prostate cancer 
knowledge, informed 
decision-making self-efficacy, 
technology use self-efficacy, 
and intention to engage in 
informed decision-making 




 Research suggests men 
involved in IDM have 
numerous benefits such as 
improved knowledge, reduce 
delusional conflict, higher 
IDM self-efficacy. 
 Increase in knowledge of 
prostate cancer  
 Categories of highest change 
were screening, anatomy, 
symptoms 
 Level I 
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 Lowest change were risk 
factors 
 Increase in participants 
confidence to figure out the 
best screening choice & 
asking medical question 
without feeling dumb.   
 Postintervention respondents 
reported that they planned to 
make an informed decision 
with their health care provider 
about whether to receive a 
PrCA screening within the 
next 6 months or mot.  
 
Conclusions: 
 iDecide led to significantly 
higher overall knowledge 
across all domains.  
 iDecide a CBDA designed for 
individuals of varying literacy 
levels, greatly improved their 
existing PrCA knowledge.  
Rim, S. H., Hall, I. J., Massetti, G. M., 
Thomas, C. C., Li, J., & Richardson, L. C. 
(2018). Primary care providers’ intended 
use of decision aids for prostate-specific 
antigen testing for prostate cancer 
screening. Journal of Cancer 
Education, 34(4), 666–670. 
https://doi.org/10.1007/s13187-018-1353-5 
Main Points: 
 Decision aids are tools 
intended to help people weigh 
the benefits and harms of 
health decisions.   
 
Type:  




 70.5% response rate for 
PCP and 41.3% for NPs.  
 Medium time of NP 
practicing medicine 
were 14 years.  
Weaknesses:  
 Study did not 
differentiate between the 





SDM may not be 
occurring and if 
providers are 
willing to 
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 Examine current primary care 
providers perspectives on use 
of decision aids.  
 
Main Findings: 
 Only 11% of providers 
currently use a DA when 
discussing PSA with pts.  
 35% of practitioners do not 
use a DA and were NOT 
interested in using one.  
 54% currently do not use a 
DA but are interested in 
learning about incorporating 
one into their practice.  
 52% of providers responded 
that they decided together with 
their patients/family member 
about PSA testing.   
 
Conclusions: 
 Provider receptivity towards 
tools can assist in and 
supplement these 
conversations about PSA 
testing.  
 Biggest impact in increasing 
PCP use may be targeting 
family practitioners who were 
most likely to not currently 
use a DA but were interested 
in using one.  
use of a patient DA and 
a physician DA. 
Why included: 
 Questions pertaining to 
prostate cancer 
screening were limited 
to primary care 
physicians and nurse 
practitioners.  
What learned: 
 Many practitioners 
routinely offer and 
recommend PSA for all 
asymptomatic pts. 
Regardless of whether 










opinion on SDM.  
Level of Evidence: 
 Level I 
  77 
 
Stamm, A. W., Banerji, J. S., Wolff, E. M., 
Slee, A., Akapame, S., Dahl, K., Massman, 
J. D., Strong, M. C., Pittenger, K. R., & 
Corman , J. M. (2017). A decision aid 
versus shared decision making for prostate 
cancer screening: results of a randomized, 
controlled trial. The Canadian Journal of 
Urology , 8339–8346.  
Main Points: 
 Shared decision making 
(SDM) is widely encouraged 
by both American Urology 
Association and Choosing 
Wisely for prostate cancer 
screening.  
 SDM is challenging due to 
time restraints and competing 
patient priorities.  
 Strategy to mitigate the 
difficulties in implementing 
SDM is to utilize a decision 
aid (DA).  
 U.S. Preventive Services Task 
Force (USPSTF) guidelines, 
which recommend against 
PSA-based prostate cancer 
screening.  
 American Cancer society 
recommends that decisions 
about prostate cancer 
screening be made in a setting 
of shared decision making- 
this setting decisions are made 
by patients in conjunction with 
provider considering current 
scientific evidence as well as 
the values and preferences of 
the individual patient 
 American Urological 
Association recommends that 
in men aged 55-69 yrs. SDM 
Strengths: 
 Approved by the 
Benaroya Research 
Institute at Virginia 
Mason’s Institutional 
Review Board.  
 Done in the U.S.  
 Questions developed by 
research team based on 
content in the VMMC 
prostate cancer 
screening DA 
 High return rate of 
questionnaires.  
  Inclusion of patients 
from multiple providers.  
 
Weaknesses:  
 Prostate cancer 
questionnaire as not 
validated and requires 
further study to 
authenticate.  
 DA may be different due 




 Completed at primary 
care offices.  
 Includes components of 
SDM.  
Light of the Whole: 
How relates: 
 DA alone is an 
inadequate 






 Compared the 
use of a DA 
alone vs. DA 
with SDM.  








Level of Evidence: 
 Level I 
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is the preferred model to 
determine whether patients 
should undergo PSA-based 
screening for prostate cancer.  
 Decision aids (DA) aim to 
underscore the exact decision 
that needs to be made, provide 
information about options, 
outcomes, risks, benefits and 
clarify personal values.  
 DA initially designed to 
complement rather than 
replace counseling by a 
provider 
 Time constraints further 
impact primary care practices 
they are increasingly 
employed as independent 
sources of information despite 




 Randomized Control Study 
 
Purpose:  
 Evaluate whether a DA with 
or without SDM during a 
primary care visit influenced 
knowledge of prostate cancer 
screening and rates of PSA-
based prostate cancer 
screening, stratifying, 
 Provides key limitations 
of SDM and key 
advantages of SDM.  
 Provides what a decision 
aid is.  
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outcomes by short term 





 3 intervention groups- usual 
care (UC), DA alone and 
SDM and DA used together  
 Patients in DA + SDM were 
significantly more likely to 
report discussing the 
possibility of diagnostic 
procedure or surgery 
compared to those in UC 
 DA group significantly less 
likely to report that they 
always felt encouraged to 
discuss all health concerns.  
 DA+SDM group answered 
more questions correctly than 
the UC group.  
 
Conclusions: 
 Providing patients, a DA 
without a personal interaction 
resulted in a greater chance of 
undergoing PSA-based 
screening without improving 
knowledge about screening or 
understanding of the 
consequences of this decision.  
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 DA + SDM were more likely 
to report that they had 
discussed the possibility of a 
procedure or intervention 
during their visit compared to 
DA alone.  
 
Roland, K. B., Milliken, E. L., Rohan, E. 
A., DeGroff, A., White, S., Melillo, S., 
Rorie, W. E., Signes, C.-A. C., & Young, P. 
A. (2017). Use of community health 
workers and Patient navigators to 
IMPROVE cancer outcomes among 
patients served by Federally qualified 
HEALTH Centers: A systematic literature 




 CHWs and patient navigators 
(PN) work to address 
disparities and improve cancer 
outcomes through education, 
connecting patients to and 
navigating them through the 
health care system, supporting 
patient adherence to screening 
and diagnostic services and 
providing social support and 
linkages to financial and 
community resources.  
 CHW/PN efforts have led to 
increase in cancer screening 
and timely completion of 
diagnostic follow-up and 
cancer treatment initiation.  
 
Type:  
  Systemic Literature Review  
Purpose:  
 First to identify studies that 
evaluated the effectiveness of 
these interventions in 
addressing cancer prevention 
Strengths: 
  All articles reviewed 
were written in the U.S.  
 All articles focused on 
cancer.  
 24 articles reviewed 
 
Weaknesses:  
 CHW/PN were more 
often supervised by 
research project 









Light of the Whole: 
How relates: 






cancer treatment.  
Similar: 
 Discussed the 
use of CHW.  
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and control disparities among 
the medically underserved 
(increasing screening, 
reducing time to diagnosis and 
treatment, and reducing 
barriers to care).  
 To subsequently describe the 
components and 
characteristics to those 




  All studies but 2 reported 
significant positive outcome 
from the CHW/PN 
intervention.  
 Screening rates improved for 
women overdue for a 
mammogram or never 
screened, women at risk for 
inadequate pap test screening 
and follow-up, and men and 
women noncompliant with 
colorectal cancer screening 
guidelines after participating 
in CHW/PN interventions.  
 
Conclusions: 
 CHW/PN programs can 
improve completion and 
timeliness of breast, cervical 
and colorectal cancer 
Level of Evidence: 
 Level I 
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screening and diagnosis 
among the medically 
underserved populations 
served by FQHCs.  
 CHW/PN partnership can 
serve unique needs of diverse 
and underserved communities 
in both clinical and 
community settings. 
 CHW/PN interventions  are 
effective in increasing cancer 
screening and the timeliness of 
diagnostic resolution among 
medically underserved 
populations  
Allen, J. D., Filson, C. P., & Berry, D. L. 
(2020). Effect of a prostate cancer 
screening decision aid for African 
American men in primary care 
settings. Cancer Epidemiology Biomarkers 




 SDM about prostate cancer 
screening is recommended but 
does not always occur.  
 DA had interactive segments 
and provided individualized 
assessment of prostate cancer 
risk.  
 Immediately after clinical 
visit, patients reported to the 
degree to which they were 
engaged by their provider in 
SDM.  
 All organizations agree that 
men should be offered the 
PSA test only after being fully 
informed about the potential 
risks and benefits of screening 
Strengths: 
 Study approved by the 
International Review 
Boards at Tufts 
University, Emory 
University school of 
medicine and the Atlanta 
VA medical Center.  
 
Weaknesses:  
 Relatively small sample.  
 Did not randomly assign 
patients to receive the 




Light of the Whole: 
How relates: 
 DA developed to 
prepare men to 
engage in SDM 
in primary care 
settings.  
Similar: 
 Describes goals 
of DA.  
 Used a pre/post 
evaluation 
design.  
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and discussing decisions with 
their health care provider 
(SDM).  
 Barriers to SDM include short 
duration of medical 
appointments and the need to 
prioritize a range of health 
concerns.  
 DA’s can effectively increase 
patients’ knowledge about 
PrCA screening, promote 
confidence in the ability to 
engage in decision-making 
with provider and decrease 
decisional conflict.  
 DA’s  advantage could be 
administered prior to medical 
visits and could increase 
meaningful patient 




 Quasi-experimental study.  
 
Purpose:  
 Determine the impact of an 
online DA on patients’ ability 
to engage in decision-making 




 Provided individualized 
assessment of prostate 
cancer risk.  
 Only 23% of men who 
undergone PSA testing 
within the past year had 
discussed the advantages 
and disadvantages of 
screening with their 
health care provider.  
 




 DA was 
delivered via 
video following 
the format of a 
popular TV 
show.  
Level of Evidence:  
 Level II 
  84 
 
 Following visit patients 
completed questionnaire that 
assessed their perceived 
involvement in SDM with 
their provider. 
 Nearly all reported that they 
would choose to undergo 
screening for PrCA before 
using DA, significantly less 
likely to choose to undergo 
screening after using DA.  
 Most felt that the DA had 
prepared them “very 
well/well” for SDM with their 
provider.  
 PCSPrep can help to prepare 
men to engage in SDM when 




 Additional research will be 
needed to better understand 
the feasibility of implementing 
the DA in primary care from 
the perspectives of providers 
and clinic staff.  
 Patient reports of engagement 
of SDM were suboptimal.  
 Provider interventions such as 
educational materials and 
reminder systems could 
improve communication skills 
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and intention to engage 
patients in preference-
sensitive decisions.  
 
Owens, O. L., Wooten, N. R., & Tavakoli, 
A. S. (2019). Development and initial 
PSYCHOMETRIC evaluation of the 
COMPUTER-BASED prostate cancer 
Screening decision aid acceptance scale for 
African American men. BMC Medical 
Research Methodology, 19(1). 
https://doi.org/10.1186/s12874-019-0776-y 
Main Points: 
 Recommendations for PrCA 
are not clear cut and evolved 
over the past two decades.  
 Recommend that men make an 
informed decision with a 
healthcare provider about 
whether to receive PrCA 
screening  
 USPSTF released draft 
recommendations that are 
more consistent with agencies 
that support informed decision 
making.  
 To engage in informed 
decision-making AA men, 
need plain language PrCA 
knowledge information and 
adequate decision self-
efficacy.  
 Questions were modified to 
refer generally to a CBDA as 
opposed to generally referring 
to a “system”.  
 
Type:  




 Study approved by IRB.  
 Completed in the U.S.  




 Pretest was only 




 Provides more 
information on another 
article in this literature 
review.  
 
Light of the Whole: 
How relates: 
 Shows that this 
specific DA 
shows promise 
as playing a key 









 Focuses on 
prostate cancer.  
 
Differs: 
 DA was 
completely 
computer based.  
Level of Evidence: 
 Level I 
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 To evaluate the psychometric 
properties of the 24-item 
Computer Based Prostate 
Cancer Screening decision aid 
Acceptance scale in AA men  
using CBDA for informed 




 Acceptance of the use of 
CBDA for PrCA screening.  
 
Conclusions: 
 Computer Based Prostate 
Cancer screening decision aid 
acceptance scale shows 
promise as playing a key role 
in increasing PrCA knowledge 
and assisting in informed 
PrCA screening decision 
making among AA men.  
 
Makarov, D., Feuer, Z., Ciprut, S., 
Martinez-Lopez, N., Fagerlin, A., Shedlin, 
M., Gold, H. T., Li, H., Lynch, G., Warren, 
R., Ubel, P., & Ravenell, J. (2021). 
Randomized trial of community Health 
Worker-led DECISION coaching to 
PROMOTE shared decision making for 
prostate cancer Screening among black 
male patients and their providers. 
https://doi.org/10.21203/rs.3.rs-128422/v2  
Main Points: 
 Nationally representative 
study of men considering PSA 
screening reported that only 
half were asked their 
preferences, and pros and cons 
of screening were discussed in 
only 32% of the time.  
 Decision coaching is the 
process by which a non-
Strengths: 
 Study completed in NYS 
 4 FNPs assisted as 
providers in the study.  
 Used American Cancer 
Society prostate cancer 




Light of the Whole: 
 
How relates: 
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 healthcare provider coach 
provides a patient with 
individualized, nondirective 
guidance to meet decision 
making needs in preparation 
for consultation with a 
healthcare provider.  
 
Type:  
 Randomized control trial  
 
Purpose:  
 To evaluate the efficacy of a 
community healthcare worker 
(CHW)- led decision-coaching 
program to facilitate SDM for 
prostate cancer screening 
among black men in the 
primary care setting with the 
aim of improving/optimizing 
decision quality.  
 
Main Findings: 
 CHWs seem ideally suited as 
decision coaches in primary 
care practices seeking to 
facilitate SDM for PSA 
screening among black men.  
 
Conclusions: 
 Ongoing study, anticipated 
that there will be an 
improvement in awareness, 
 Study is currently 
ongoing.  
 Completion anticipated 
for March 2023.  
Why included: 
 Different approach to 
SDM 
 
 Used in primary 
care settings.  
Similar: 





 DA is provided 
in mail.  
 CHW led 
decision occurs 
1hr prior to 
appointment.  
Level of Evidence:  
 Level I 
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knowledge, support, and 
efficacy to reduce the impact 
of chronic disease and cancer 
in underserved populations 
when CHW is used.  
 
Allen, J. D., Reich, A., Cuevas, A. G., & 
Ladin, K. (2019). Preparing African 
American men to make informed prostate 
cancer screening decisions: Development 
and pilot testing of an interactive online 
decision aid (preprint). 
https://doi.org/10.2196/preprints.15502  
Main Points: 
 DA are promising means to 
prepare men to engage in 
SDM and can be administered 
before a clinical visit.  
 Development and pilot testing 
of an interactive individually 
tailored web-based DA 
designed specifically for AA 
men.  
Type:  
 Quasi-experimental Study.  
Purpose:  
 Aimed to describe the 
development and pilot testing 
of an interactive web-based 
decision aid; prostate cancer 
screening preparation 
(PCSPrep)  for African 
American men designed 
informed decision making for 
prostate cancer screening. 
Main Findings: 
 DAs found to be effective 
interventions to complement 
patient/provider engagement 
in SDM by providing patients 
Strengths: 
 Completed in the U.S. 
 Addressed issues with 
false-positives tests 
results in the DA.  
 
Weaknesses:  
 Small convenience 




 Decision aid that is 
discussed is for prostate 
cancer screening.  
 
 
Light of the Whole: 
 
How relates: 
 Proves that DA’s 
have been found 
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with information needed to 
assess their options and 
examine their values as they 
relate to those options.  
 It has been suggested that 
offering DAs for prostate 
cancer screening outside of a 
clinical setting may be 
particularly important to AA 
men who report difficulty 
communicating with medical 
providers and may have a high 
level of medical mistrust.  
 PCSPrep to be feasible to 
administer in community 
settings even among those 
who reported low levels of 
computer skills.  
 High levels of agreement 
when asked the extent to 
which PCSPrep helped 
prepare them to organize their 
thinking, make decision and 
have conversations about 
screening with their provider.  
Conclusions: 
 Decision support may improve 
the accuracy of disease risk 
among this population and at 
the same time enable men to 
make decisions without undue 




Level of Evidence: 
 Level II 
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Alizadeh-Sabeg, P., Mehrabi, E., 
Nourizadeh, R., Hakimi, S., & Mousavi, S. 
(2021). The effect of motivational 
interviewing on the change of breast cancer 
screening behaviors among Rural Iranian 
women. Patient Education and 
Counseling, 104(2), 369–374. 
https://doi.org/10.1016/j.pec.2020.08.011 
Main Points: 
 Education may raise women’s 
awareness of breast cancer, 
but it is not adequate alone.  
 61% of women in Saudi 
Arabia had high knowledge of 
mammography but less than 
1/3 have had a mammography 
preformed.  
 Regular screening depends 
largely on motivational 
factors, especially one’s 
perception of the risk of 
disease and impact of 
screening behaviors on 
reducing the risk of breast 
cancer.  
 MI is considered as a client-
centered approach aimed at 
improving the motivation of 
clients to change their 
behavior.  
Type:  
 Randomized Control Trial  
Purpose:  
 To determine the effect of 
motivational interviewing 
(MI) on the change of breast 
cancer screening behaviors 
among rural Iranian Women 
Main Findings: 
 Most participants were at the 
contemplation stage before the 
Strengths: 
 Provided educational 
booklet to participants 
along with counseling 
sessions.  
 Counseling provided by 
certified counselor in 
MI.  
Weaknesses:  
 Not completed in U.S. 
 Done on breast cancer 
not prostate cancer.  
 Did not provide 
education during MI.  
 
Why included: 





Light of the Whole 










 Participants from 
low 
socioeconomic 
status and lack of 
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intervention while at the end 
of most individuals in the 
intervention group entered 
action stage for self-breast 
checking and CBE.  
 Only 16 participants entered 
action phase for mammogram.  
Conclusions: 
 MI-based counseling 
increased the Iranian rural 
women’s motivation for 
displaying breast cancer 
screening behaviors.  
 
 Sessions were in 
groups of 5-7 
participants.  
 
Level of Evidence:  
 Level I 
Stacey, D., Kryworuchko, J., Bennett, C., 
Murray, M. A., Mullan, S., & Légaré, F. 
(2012). Decision coaching to Prepare 
patients for making health 
decisions. Medical Decision Making, 32(3). 
https://doi.org/10.1177/0272989x12443311 
Main Points: 
 Decision coaching aims to 
develop patients’ confidence 
and skills in deliberating about 
options and helps prepare 
patients to discuss decisions 
with their practitioner.  
 Decision coaching refers to 
the process by which a 
supportive and knowledgeable 
health professional provides a 
patient with individualized 
nondirective guidance to meet 
decision-making needs in 
preparation for consultation 
with the person responsible for 
ultimately sharing the decision 
with patient.  
 
Strengths: 
 Compared decision 
coaching, decision aid 
and neither.  
 
Weaknesses:  
 Not within 5 years.  
 Did not include articles 
that had decision 
coaching without having 
a DA.  
 
Why included: 
 Trials included in the 
study some focused on 
decisions related to 
prostate cancer 
screening.  
Light of the Whole: 




the health care 
team is a strategy 
for ensuring that 
DA are provided 
and discussed 





with use of 
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Type:  
 Systemic Review of 
Randomized Control Trial  
 
Purpose:  
 To explore characteristics and 
effectiveness of decision 
coaching evaluated within 
trials of patient decision aids 
(PtDAs) for health decisions.  
 
Main Findings: 
 Coaching compared with 
usual care improved 
knowledge. 
 Coaching plus PtDAs with 
usual care improved 
knowledge and participation 
in decision making without 
reported dissatisfaction.  
 Coaching versus usual care- 
women had higher knowledge 
of breast cancer genetic testing 
with decision coaching over 
those who only had usual care.  
 No difference in measured 
knowledge between coaching 
and PtDA alone.  
 More consistent values seen in 
women exposed to coaching 
vs PtDA alone.  
 4 trials measured 
satisfaction.  
 
coaching and a 
DA.  
Differs: 







Level of Evidence:  
 Level I 
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 Coaching plus PtDA vs PtDA 
alone there was no difference 




 Growing interest in decision 
coaching.  
 Decision coaching appears to 
improve knowledge .   
  
Palmas, W., March, D., Darakjy, S., 
Findley, S. E., Teresi, J., Carrasquillo, O., 
& Luchsinger, J. A. (2015). Community 
health worker interventions to improve 
glycemic control in people with diabetes: A 
systematic review and meta-
analysis. Journal of General Internal 
Medicine, 30(7), 1004–1012. 
https://doi.org/10.1007/s11606-015-3247-0  
Main Points: 
 Education from a certified 
diabetes educator.  
 Components in the articles 
differed substantially.  
 
Type:  




 To review the efficacy of 
community health worker 
interventions to improve 




 CHW interventions lasting at 
least 12 months result in 
modest reduction in Alc, 
compared to usual care.  
Strengths: 
 Used an outpatient 
setting.  
 Primarily used 
MEDLINE for literature 
search.  
Weaknesses: 
 Studied mostly minority 
populations 
 Detailed data describing 
the exact number of 
CHW participant 
encounters was not 
available for several 
studies.   
 
Why included: 
 Integrated CHW 
intervention with 
patients PCP. 




reduced the A1c 
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 Studies with more visit 
intensive CHW protocol might 
have shown greater efficacy. 
  
Conclusions: 
 CHW interventions showed a 
modest reduction in Alc 








Level of Evidence: 
 Level I 
Alaofè, H., Asaolu, I., Ehiri, J., Moretz, H., 
Asuzu, C., Balogun, M., Abosede, O., & 
Ehiri, J. (2017). Community health workers 
in Diabetes prevention and management in 
developing countries. Annals of Global 




 Outcomes included increased 
knowledge of T2DM 
symptoms and prevention 
measures; increased adoption 
of treatment-seeking and 
prevention measures; 
increased medication 
adherence and improved 
fasting  blood sugar, glycated 
hemoglobin, and BMI.  
 Pt. education- an inexpensive 
and effective diabetes 
management option is not 
practiced routinely.  
 CHWs serve as bridges among 
their ethnic, cultural, or 
geographic communities and 
health care providers.  
 
Type:  









 Limited research 
reviewed.  
 Study not done in the 
U.S. 
 
Why included:  
 Touched based on CHW 
and high-income 
countries- have also 
improved health 
behaviors & outcomes.  
 CHW improve 
knowledge and health 
outcomes.  
 
Light of the Whole: 
How relates:  
 
 Shows positive 
outcomes with 








 Articles focused 
on T2DM. 
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 To critically appraise evidence 
regarding the effectiveness of 
CHW interventions for 
prevention and management of 
type 2 diabetes mellitus 
(TDM) in low-and middle-
income countries (LMICs).  
 
Main Findings: 
 Positive outcomes in 7 out of 
10 articles.  
 One article had health 
volunteers provide nutritional 
education and established 
appropriate daily exercise 
activities for 3 months- mean 
score for health promotion 
behavior was significantly 
higher after intervention.  
 
Conclusions: 
 CHW have potential to 
improve knowledge, health 
behavior and health outcomes 
related to prevention and 
management of T2DM in 
LMICs.  
 Further research is needed into 
the influence of CHWs on 
disease awareness, health 





Level of Evidence:  
 Level V 
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Portillo, E. M., Vasquez, D., & Brown, L. 
D. (2020). Promoting Hispanic Immigrant 
health via community health workers and 
motivational interviewing. International 
Quarterly of Community Health 




 Examines three innovative 
strategies designed to 
overcome the health 
disparities Hispanic 
immigrants face; the use of 
CHW, vouchers for 
preventative health services 
and motivational interviewing  
(MI) 
 Strategies were implemented 
in a health promotion program 
called Healthy Fit. 
 CHW conducted brief MI 
aimed at enhancing the 
participants intrinsic 
motivation to follow through 
and complete health behavior 
changes.   
 
Type:  
 Program Evaluation  
 
Purpose:  
 Examine three innovative 
strategies designed to 
overcome the health 
disparities Hispanic 
immigrants face.  
 
Main Findings: 
 CHW help participants conner 
with liaisons who serve as a 
Strengths:  
 Discusses the use of 
CHW and MI.  
Weaknesses: 
 Specifically looking at 
Healthy Fit program.  
Why included: 
 CHW are conducting the 
motivational interview.  
Light of the Whole: 
How relates: 













 Healthy fit 
program reaches 
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bridge between health care 
providers and the community.  
 Use of MI enriches 
conversation between CHW 
and participants, helping 




 Combination of all three 
strategies makes healthy fit a 
promising low-cost program 




 Focuses on the 
Healthy Fit 
program. 
Level of Evidence: 
 Level V 
Brandford, A., Adegboyega, A., Combs, B., 
& Hatcher, J. (2018). Training community 
health workers in motivational interviewing 
to promote cancer screening. Health 
Promotion Practice, 20(2), 239–250. 
https://doi.org/10.1177/1524839918761384  
Main Points: 
 CHWs are increasingly being 
used in cancer prevention and 
control efforts.  
 CHWs are frontline public 
health workers who have a 
close understanding of the 
community.  
 Goal of CHWs is to increase 
health knowledge and self-
sufficiency through a range of 
activities such as outreach, 
community education, social 




 Completed in the U.S.  
 
Weaknesses:  
 Limited information on 
training of all CHWs.  
 
Why included: 
 Includes training for 
CHW with MI.  
 Discussed CHW with 
cancer prevention.  
 
Light of the Whole: 
How relates:  
 CHWs agreed 
that the use of 
MI is feasible 








 CHW goals are 
to increase 
health 
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 Literature Review.  
Purpose: 
 To describe the feasibility of 
training CHWs to deliver 
motivational interviewing 
intervention to promote cancer 




 Participants receiving the MI 
intervention tended to be more 
specific and detailed in listing 
tangible barriers to 
mammography.  
 Challenges making the 
training meaningful for all 
levels of CHWs.  
 MI is a successful and feasible 
technique for a CHW to 
promote cancer screening.  
 Training increased confidence 
and provided the CHWs with 
a skill set that could be 
adapted to meet the needs of 
the community served.  
 
Conclusions: 
 Most powerful strategies to 
address cancer disparities is 




 Focuses on 
training for 
CHW to conduct 
motivational 
interviewing.  
Level of Evidence: 
 Level V 
  99 
 
behavior surrounding cancer 
screenings.  
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Appendix B: Decision Aid  
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Appendix C: COMRADE Tool  
Satisfaction with Communication 
 
1. The doctor made me aware of the different treatments available.  
 
Strongly Agree  Agree  Neutral  Disagree Strongly Disagree 
 
2. The doctor gave me the chance to express my opinions about the different treatments available.  
 
Strongly Agree  Agree  Neutral   Disagree Strongly Disagree 
 
3. The doctor gave me the chance to ask for as much information as I needed about the different 
treatment choices.  
 
Strongly Agree  Agree  Neutral  Disagree Strongly Disagree 
 
4. The doctor gave me enough information about the treatment choices available.  
 
Strongly Agree  Agree  Neutral  Disagree Strongly Disagree 
 
5. The doctor gave enough explanation of the information about treatment choices. 
  
Strongly Agree  Agree  Neutral  Disagree Strongly Disagree 
 
6. The information given to me was easy to understand. 
 
Strongly Agree  Agree  Neutral   Disagree Strongly Disagree 
  
7. I know the advantages of treatment or not having treatment. 
 
Strongly Agree  Agree  Neutral  Disagree Strongly Disagree 
  
8. I know the disadvantages of treatment or not having treatment. 
 
Strongly Agree  Agree  Neutral  Disagree Strongly Disagree 
 
9. The doctor gave me a chance to decide which treatment I thought was best for me.  
 
Strongly Agree  Agree  Neutral  Disagree Strongly Disagree 
 
10. The doctor gave me a chance to be involved in the decisions during the consultation. 
 
Strongly Agree  Agree  Neutral   Disagree Strongly Disagree 
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Confidence in Decision  
1. Overall, I am satisfied with the information I was given.  
 
Strongly Agree  Agree  Neutral   Disagree Strongly Disagree 
 
2. My doctor and I agreed about which treatment (or no treatment) was best for me.  
 
Strongly Agree  Agree  Neutral  Disagree Strongly Disagree 
 
3. I can easily discuss my condition again with my doctor.  
 
Strongly Agree  Agree  Neutral  Disagree Strongly Disagree 
 
4. I am satisfied with the way in which the decision was made in the consultation.  
 
Strongly Agree  Agree  Neutral  Disagree Strongly Disagree 
 
5. I am sure that the decision made was the right one for me personally.  
 
Strongly Agree  Agree  Neutral   Disagree Strongly Disagree 
 
6. I am satisfied that I am adequately informed about the issues important to the decision.  
 
Strongly Agree  Agree  Neutral   Disagree Strongly Disagree 
 
7. It is clear which choice is best for me.  
 
Strongly Agree  Agree  Neutral   Disagree Strongly Disagree 
 
8. I am aware of the treatment choices I have.  
 
Strongly Agree  Agree  Neutral   Disagree Strongly Disagree 
 
9. I feel an informed choice has been made.  
 
Strongly Agree  Agree  Neutral  Disagree Strongly Disagree 
 
10. The decision shows what is important to me.  
 
Strongly Agree  Agree  Neutral  Disagree Strongly Disagree 
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Appendix E: Budget Table  
Cost Activity Amount Type 





*Calculated based on the average NP 
hourly rate in the geographical area 
for 10 hours of preparation 
Direct/Fixed  
30-Minute Introduction 
Meeting and 1-Hour Training 
Session Attendance  
(2 NPs, 1 RN, 2 LPN 1 office 
manager, 2 secretaries) 
$559.5 
 
* Calculated based on the average 
hourly rate in the geographical area 
Direct/Fixed  
1-Hour NP Video Training 
 
$180.00 Direct/Fixed 
Patient Materials  
(Decision Aid, Pre- & Post-
Questionnaire, COMRADE 




*Calculated based on $0.08 per page 
printed front & back, $0.15 per page 
for color printed front & back & $1.00 
per folder for 50 patients 
Direct/Fixed  




*Calculated based on the average rate 
for a videographer in the geographical 
area 
Direct/Fixed 
Staff Education Materials   




*Calculated based on $0.08 per page 
print front and back 
Direct/Fixed 
1-Hour IT  




*Calculated based on the average IT 
hourly rate in the geographical area 






*Calculated based on $0.08 per page 
printed front only (printed 50 flyers) 
Direct/Fixed 









Billable 30–45 minute Nurse 
Practitioner visit.  
$5,100.00 
 
*Calculated based on the 
average rate of billable hour 
& 30 patients.  
Direct/ fixed 
Saved Insurance Costs $13,100 
 
*Calculated based on cost of 
radiation for 30 days verses 
radical prostatectomy.  
Direct/ fixed 
Patient Retention from 
Satisfaction. (15 patients will 




*Calculated based on the 
average rate of billable hour 
& one physical a year.  
Direct/ fixed 
Patient Recruitment. (Each 
participant will recruit 1 one 
friend to participant in study) 
$5,100.00 
 
*Calculated based on the 
average rate of billable hour 
& 30 recruitments.  
Direct/ fixed 
Total Gains $25,850.00 Variable 
 
Total Costs $1,746.64  
Total Benefits $25,850.00  
 Cost/Benefit Amount $24,103.36  
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Appendix F: Recruitment Flyer 
Prostate Cancer Are YOU at 
Risk? 
 
 Are you a fireman, police officer or 
detective? 
 Are you concerned about your risk of 
developing prostate cancer? 
 
Watch this short YouTube Video to find 
out more information about this study and 
to potentially participate.  
Scan QR Code to be redirected to the YouTube Video.  
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Information that will be include in the YouTube video that will recruit participants. 
 
Information about Prostate Cancer.   
 What is prostate cancer? 
o Prostate cancer is a form of cancer that begins in the gland cells of the prostate, 
and it is only found in males.  
 Risk factors: 
o Age, family history of prostate cancer, ethnicity and recently occupation.  
 Statistics on prostate cancer: 
o In 2018 211,893 were diagnosed with prostate cancer and 31,488 men died from 
the disease.  
 
Information about the Study and who can participate.   
 What the program consists of: 
o The study will consist of one nurse practitioner led decision coaching session.  
o You will be asked to complete documentation that will establish your knowledge 
of prostate cancer and evaluate your satisfaction with the decision coaching 
session and your confidence in decision making.  
o At the completion of decision coaching session, you will be asked if you would 
like to have your PSA tested.  
o All information will remain confidential.  
 Who can participate in the study? 
o Males greater than age 40 
o Protective Service Occupation 
o Volunteer Firemen  
 What is a Protective service occupation? 
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Appendix H: Staff and Nurse Education 
taff Education  
 
 
 Patients’ paperwork (informed consent, pre- and post- questionnaire, & COMRADE tool) 
will be identified by a number associated with their chart to maintain confidentiality.  
o Example: Name- John Doe- #0046  
 Nurse practitioner led decision coaching will provide education to protective service 
occupations about prostate cancer and PSA testing.  
 The goal of this proposal is to improve knowledge about prostate cancer, increase the 
number of individuals getting PSA testing done.  
 Other goals include improved satisfaction with shared decision making and improved 









 Frequently check google forms email for responses to participate in study.  
 When responses are received, reach out to individual who completed the google form.  
 Educated them on purpose of study and review informed consent.  
 Send informed consent and pre-questionnaire to patients after phone conversation.  
 During decision coaching frequently refresh EMR to see if PSA testing was ordered, if so, go to 
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What you will be educating the participants: 
 Anatomy & Function 
o Prostate gland is a reproductive organ located below the bladder.  
o The prostate gland makes some of the fluid that is part of semen.  
 Risk factors 
o Age increases your risk of developing prostate cancer.  
o African American ethnicity has higher diagnosis rate than Caucasians.  
o Family history of prostate cancer increases your risk of being diagnosed with 
prostate cancer.  
 Screening 
o PSA stands for prostate specific antigen; it is a protein made by the prostate gland 
and can be found in the blood. An increased PSA may indicate prostate cancer.  
o DRE also known and digital rectal exam is done to establish if any nodules or 
tumors can be felt on the prostate gland.  
o A biopsy of the prostate gland is the only way to properly diagnose prostate 
cancer.  
o Prostate cancer biopsy is a procedure that will remove samples of suspicious 
tissue from the prostate gland.  
o PSA testing and DRE are not definitive in diagnosing prostate cancer. 
o Risks related to PSA testing.  
 Symptoms 
o Sign and symptoms of prostate cancer include trouble urinating, decreased force 
in the stream of urine, blood in urine or semen, bone pain, losing weight without 
trying and erectile dysfunction.  
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Yes No Referred 
to 
Urology 




#01         
#02         
#03         
#04         
#05         
#06         
#07         
 
